Aşı (tıp) (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Aşı (tıp)" in Turkish language version.

refsWebsite

Global rank Turkish rank

98web.archive.org

1^st place

91nih.gov

4^th place

11^th place

86doi.org

2^nd place

4^th place

20worldcat.org

5^th place

8^th place

16cdc.gov

218^th place

269^th place

8who.int

195^th place

162^nd place

6books.google.com

3^rd place

5^th place

3archive.org

6^th place

3vaccines.gov

low place

3fda.gov

447^th place

858^th place

2nytimes.com

7^th place

36^th place

2harvard.edu

18^th place

47^th place

2theguardian.com

12^th place

44^th place

2handle.net

102^nd place

447^th place

2washingtonpost.com

34^th place

131^st place

2historyofvaccines.org

low place

2chop.edu

low place

2statnews.com

8,771^st place

low place

2hhs.gov

5,973^rd place

low place

2bmjjournals.com

low place

1iowa.gov

8,907^th place

low place

1jhu.edu

699^th place

1,123^rd place

1healthychildren.org

low place

1sciencedirect.com

149^th place

154^th place

1npr.org

92^nd place

369^th place

1tribune.com.pk

595^th place

1,535^th place

1nature.com

234^th place

284^th place

1escholarship.org

1,523^rd place

903^rd place

1tandfonline.com

507^th place

425^th place

1coastalcarolinaresearch.com

low place

1emory.edu

4,363^rd place

4,908^th place

1bioprocessintl.com

low place

1smithsonianmag.com

503^rd place

1,288^th place

1cnn.com

28^th place

76^th place

1horizonpress.com

low place

1mercksource.com

8,363^rd place

4,739^th place

1pediatriconcall.com

low place

1psu.edu

207^th place

424^th place

1vaccinesafety.edu

low place

1npl.co.uk

8,830^th place

low place

1nationalpost.com

818^th place

1,683^rd place

1centerforhealthsecurity.org

low place

1cdsco.gov.in

low place

1aappublications.org

3,763^rd place

3,415^th place

1nhs.uk

1,989^th place

1,187^th place

1europa.eu

68^th place

79^th place

1precisionnanomedicine.com

low place

1ourworldindata.org

2,263^rd place

2,284^th place

1ctvnews.ca

768^th place

2,814^th place

1vaccine-safety-training.org

low place

1publishing.service.gov.uk

1,877^th place

6,549^th place

1ghostarchive.org

32^nd place

292^nd place

1ft.com

210^th place

338^th place

1abc.net.au

139^th place

531^st place

1smh.com.au

132^nd place

441^st place

1brw.com.au

low place

1thehindu.com

52^nd place

1,448^th place

1news-medical.net

8,069^th place

6,420^th place

1ugent.be

3,695^th place

4,261^st place

1bartleby.com

1,295^th place

384^th place

1lexology.com

low place

1technologyreview.com

1,943^rd place

3,663^rd place

1columbia.edu

488^th place

499^th place

1japantimes.co.jp

389^th place

606^th place

1lww.com

2,769^th place

2,544^th place

1vox.com

484^th place

789^th place

1theconversation.com

928^th place

1,973^rd place

1childrenshospital.org

low place

1semanticscholar.org

11^th place

589^th place

1wired.com

193^rd place

377^th place

1newsweek.com

269^th place

619^th place

aappublications.org

aapredbook.aappublications.org

"Vaccine Status Table". Red Book Online. American Academy of Pediatrics. 26 Nisan 2011. 27 Aralık 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Ocak 2013.

abc.net.au

WHO to trial Nanopatch needle-free delivery system| ABC News, 16 Sep 2014| "Needle-free polio vaccine a 'game-changer'". ABC News. 16 Eylül 2014. 2 Nisan 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Eylül 2015.

archive.org

Grammatikos AP, Mantadakis E, Falagas ME (June 2009). "Meta-analyses on pediatric infections and vaccines". Infectious Disease Clinics of North America. 23 (2): 431-457. doi:10.1016/j.idc.2009.01.008. PMID 19393917.
Fenner, F.; Henderson, D.A.; Arita, I.; Jezek, Z.; Ladnyi, I.D. (1988). Smallpox and its Eradication. Cenevre: World Health Organization. ISBN 92-4-156110-6.
Van Sant JE (2008). "The Vaccinators: Smallpox, Medical Knowledge, and the 'Opening' of Japan". J Hist Med Allied Sci. 63 (2): 276-279. doi:10.1093/jhmas/jrn014.

bartleby.com

Voltaire (1742). "Letter XI". Letters on the English.

bioprocessintl.com

Scott (April 2004). "Classifying Vaccines" (PDF). BioProcesses International: 14-23. 12 Aralık 2013 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 9 Ocak 2014.

bmjjournals.com

fn.bmjjournals.com

Dunn PM (January 1996). "Dr Edward Jenner (1749-1823) of Berkeley, and vaccination against smallpox" (PDF). Archives of Disease in Childhood: Fetal and Neonatal Edition. 74 (1): F77-78. doi:10.1136/fn.74.1.F77. PMC 2528332 $2. PMID 8653442. 8 Temmuz 2011 tarihinde kaynağından (PDF) arşivlendi.

bmj.bmjjournals.com

Wolfe R, Sharp L (2002). "Anti-vaccinationists past and present". BMJ. 325 (7361): 430-2. doi:10.1136/bmj.325.7361.430. PMC 1123944 $2. PMID 12193361. 25 Ağustos 2006 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.

books.google.com

Stanciu, Stefan G. (24 Ağustos 2016). Micro and Nanotechnologies for Biotechnology (İngilizce). BoD – Books on Demand. ISBN 978-953-51-2530-3. 14 Ocak 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Nisan 2022.
Sinha JK, Bhattacharya S. A Text Book of Immunology (Google Books Preview). Academic Publishers. s. 318. ISBN 978-81-89781-09-5. Erişim tarihi: 9 Ocak 2014.
Gomez, Phillip L.; Robinson, James M.; Rogalewicz, James (2008). "Chapter 4: Vaccine Manufacturing". Plotkin, Stanley A.; Orenstein, Walter A.; Offit, Paul A. (Ed.). Vaccines (5. bas.). New York: Saunders Elsevier. ss. 45-58. ISBN 9781437721584. Erişim tarihi: 26 Mart 2021.
American Medicine. American-Medicine Publishing Company. 1926.
South African Institute for Medical Research (1929). Annual report [Jaarverslag]. South African Institute for Medical Research – Suid-Afrikaanse Instituut vir Mediese Navorsing.
Khan, Firdos Alam (20 Eylül 2011). Biotechnology Fundamentals. CRC Press. s. 270. ISBN 978-1-4398-2009-4.

brw.com.au

"Vaxxas raises $25m to take Brisbane's Nanopatch global". Business Review Weekly. 10 Şubat 2015. 16 Mart 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mart 2015.

cdc.gov

"Immunization: The Basics". Centers for Disease Control and Prevention. 22 Kasım 2022. 12 Temmuz 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 Temmuz 2023.
United States Centers for Disease Control and Prevention (2011). A CDC framework for preventing infectious diseases. 29 Ağustos 2017 tarihinde Wayback Machine sitesinde arşivlendi. Accessed 11 September 2012. "Vaccines are our most effective and cost-saving tools for disease prevention, preventing untold suffering and saving tens of thousands of lives and billions of dollars in healthcare costs each year."
"Measles Vaccination CDC". 5 Şubat 2018. 19 Kasım 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
"Measles – United States, January 1 – April 25, 2008". MMWR. Morbidity and Mortality Weekly Report. 57 (18): 494-498. May 2008. PMID 18463608. 11 Ekim 2017 tarihinde kaynağından arşivlendi.
"Possible Side-effects from Vaccines". Centers for Disease Control and Prevention. 12 Temmuz 2018. 17 Mart 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Şubat 2014.
"Seasonal Flu Shot – Seasonal Influenza (Flu)". CDC. 2 Ekim 2018. 1 Ekim 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 17 Eylül 2017.
"HPV Vaccine | Human Papillomavirus | CDC". www.cdc.gov. 13 Mayıs 2019. 18 Haziran 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Haziran 2019.
"Understanding and Explaining Viral Vector COVID-19 Vaccines". Centers for Disease Control and Prevention. 2 Şubat 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 13 Mart 2021.
CDC (11 Şubat 2020). "COVID-19 and Your Health". Centers for Disease Control and Prevention. 3 Mart 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 Aralık 2020.
CDC (12 Temmuz 2018). "Ingredients of Vaccines – Fact Sheet". 17 Aralık 2009 tarihinde kaynağından arşivlendi. Erişim tarihi: 20 Aralık 2009.
Centers for Disease Control and Prevention (12 Kasım 2020), U.S. Vaccine Names, 21 Ağustos 2021 tarihinde kaynağından arşivlendi, erişim tarihi: 21 Ağustos 2021.
Centers for Disease Control and Prevention (7 Ağustos 2018), Tetanus (Lockjaw) Vaccination, 16 Mayıs 2016 tarihinde kaynağından arşivlendi, erişim tarihi: 21 Mayıs 2016.
Centers for Disease Control and Prevention (2 Şubat 2018), Vaccine Acronyms and Abbreviations [Abbreviations used on U.S. immunization records], 2 Haziran 2017 tarihinde kaynağından arşivlendi, erişim tarihi: 22 Mayıs 2017.
"ACIP Vaccine Recommendations Home Page". CDC. 15 Kasım 2013. 31 Aralık 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Ocak 2014.
"HPV Vaccine Safety". Centers for Disease Control and Prevention (CDC). 20 Aralık 2013. 10 Kasım 2009 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Ocak 2014.
Dooling, Kathleen (13 Ağustos 2021). "The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine – United States, December 2020" (PDF). CDC the Advisory Committee on Immunization Practices. 69 (5152): 1657-1660. PMC 9191902 $2. PMID 33382671. 19 Ağustos 2021 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 18 Nisan 2023.

cdsco.gov.in

"home". Cdsco.gov.in. 15 Nisan 2021. 4 Ocak 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Ocak 2022.

centerforhealthsecurity.org

Toner E, Barnill A, Krubiner C, Bernstein J, Privor-Dumm L, Watson M, Martin E, Potter C, Hosangadi D, Connell N, Watson C, Schoch-Spana M, Veenema TG, Meyer D, Biddison EL, Regenberg A, Inglesby T, Cicero A (2020). Interim Framework for COVID-19 Vaccine Allocation and Distribution in the United States (PDF). Baltimore, MD: Johns Hopkins Center for Health Security. 22 Ağustos 2020 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 24 Ağustos 2020.

childrenshospital.org

"Frequently Asked Questions (FAQ)". Boston Children's Hospital. 17 Ekim 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Şubat 2014.

chop.edu

Philadelphia, The Children's Hospital of (18 Ağustos 2014). "A Look at Each Vaccine: Hepatitis B Vaccine". www.chop.edu. 31 Mayıs 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Haziran 2019.
Offit, Paul A. (2020). "Making vaccines: Licensure, recommendations and requirements". Children's Hospital of Philadelphia. 8 Eylül 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 20 Ağustos 2020.

cnn.com

edition.cnn.com

McKenzie, David (26 Mayıs 2018). "Fear and failure: How Ebola sparked a global health revolution". CNN. 26 Ağustos 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 26 Mayıs 2018.

coastalcarolinaresearch.com

"Types of Vaccines". coastalcarolinaresearch.com. 3 Mayıs 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Mayıs 2019.

columbia.edu

cuimc.columbia.edu

"Katalin Karikó and Drew Weissman Awarded Horwitz Prize for Pioneering Research on COVID-19 Vaccines". Columbia University Irving Medical Center (İngilizce). 12 Ağustos 2021. 16 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Eylül 2021.

ctvnews.ca

Christy Somos (7 Mayıs 2021). "Everything you need to know about the WTO's COVID-19 vaccine patent proposal". CTV News. 23 Mayıs 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 23 Mayıs 2021.

doi.org

Amanna, Ian J.; Slifka, Mark K. (2018). "Successful Vaccines". Current Topics in Microbiology and Immunology. Plant Disease. 428. Springer International Publishing. ss. 1-30. doi:10.1007/82_2018_102. eISSN 2196-9965. ISBN 978-3-030-58003-2. ISSN 0070-217X. PMC 6777997 $2. PMID 34129355. The effect of vaccines on public health is truly remarkable. One study examining the impact of childhood vaccination on the 2001 US birth cohort found that vaccines prevented 33,000 deaths and 14 million cases of disease (Zhou et al. 2005). Among 73 nations supported by the GAVI alliance, mathematical models project that vaccines will prevent 23.3 million deaths from 2011–2020 compared to what would have occurred if there were no vaccines available (Lee et al. 2013). Vaccines have been developed against a wide assortment of human pathogens.
Melief CJ, van Hall T, Arens R, Ossendorp F, van der Burg SH (September 2015). "Therapeutic cancer vaccines". The Journal of Clinical Investigation. 125 (9): 3401-3412. doi:10.1172/JCI80009. PMC 4588240 $2. PMID 26214521.
Bol KF, Aarntzen EH, Pots JM, Olde Nordkamp MA, van de Rakt MW, Scharenborg NM, de Boer AJ, van Oorschot TG, Croockewit SA, Blokx WA, Oyen WJ, Boerman OC, Mus RD, van Rossum MM, van der Graaf CA, Punt CJ, Adema GJ, Figdor CG, de Vries IJ, Schreibelt G (March 2016). "Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity". Cancer Immunology, Immunotherapy. 65 (3): 327-339. doi:10.1007/s00262-016-1796-7. PMC 4779136 $2. PMID 26861670.
Brotherton J (2015). "HPV prophylactic vaccines: lessons learned from 10 years experience". Future Virology. 10 (8): 999-1009. doi:10.2217/fvl.15.60.
Frazer IH (May 2014). "Development and implementation of papillomavirus prophylactic vaccines". Journal of Immunology. 192 (9): 4007-4011. doi:10.4049/jimmunol.1490012. PMID 24748633.
Ledford, Heidi (17 Ağustos 2020). "What the immune response to the coronavirus says about the prospects for a vaccine". Nature (İngilizce). 585 (7823): 20-21. Bibcode:2020Natur.585...20L. doi:10.1038/d41586-020-02400-7. PMID 32811981.
Lombard M, Pastoret PP, Moulin AM (April 2007). "A brief history of vaccines and vaccination". Revue Scientifique et Technique. 26 (1): 29-48. doi:10.20506/rst.26.1.1724. PMID 17633292.
Behbehani AM (December 1983). "The smallpox story: life and death of an old disease". Microbiological Reviews. 47 (4): 455-509. doi:10.1128/MMBR.47.4.455-509.1983. PMC 281588 $2. PMID 6319980.
Baxby D (January 1999). "Edward Jenner's Inquiry; a bicentenary analysis". Vaccine. 17 (4): 301-307. doi:10.1016/s0264-410x(98)00207-2. PMID 9987167.
Pasteur, Louis (1881). "Address on the Germ Theory". Lancet. 118 (3024): 271-272. doi:10.1016/s0140-6736(02)35739-8.
Clem, Angela S (2011). "Fundamentals of Vaccine Immunology". Journal of Global Infectious Diseases. 3 (1): 73-78. doi:10.4103/0974-777X.77299. ISSN 0974-777X. PMC 3068582 $2. PMID 21572612.
Grammatikos AP, Mantadakis E, Falagas ME (June 2009). "Meta-analyses on pediatric infections and vaccines". Infectious Disease Clinics of North America. 23 (2): 431-457. doi:10.1016/j.idc.2009.01.008. PMID 19393917.
Wiedermann, Ursula; Garner-Spitzer, Erika; Wagner, Angelika (2016). "Primary vaccine failure to routine vaccines: Why and what to do?". Human Vaccines & Immunotherapeutics. 12 (1): 239-243. doi:10.1080/21645515.2015.1093263. ISSN 2164-554X. PMC 4962729 $2. PMID 26836329.
Reda, Shereen M.; Cant, Andrew J. (May 2015). "The importance of vaccination and immunoglobulin treatment for patients with primary immunodeficiency diseases (PIDs) - World PI Week April 22-29, 2015: FORUM". European Journal of Immunology (İngilizce). 45 (5): 1285-1286. doi:10.1002/eji.201570054. PMID 25952627. Erişim tarihi: 18 Nisan 2022.
Jo, Eun-Kyeong (December 2019). "Interplay between host and pathogen: immune defense and beyond". Experimental & Molecular Medicine (İngilizce). 51 (12): 1-3. doi:10.1038/s12276-019-0281-8. ISSN 2092-6413. PMC 6906370 $2. PMID 31827066.
Gomes, M. Gabriela M.; White, Lisa J.; Medley, Graham F. (21 Haziran 2004). "Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives". Journal of Theoretical Biology. 228 (4): 539-549. Bibcode:2004JThBi.228..539G. doi:10.1016/j.jtbi.2004.02.015. hdl:10400.7/53. ISSN 0022-5193. PMID 15178201. 19 Nisan 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Nisan 2022.
Bonanni, Paolo; Picazo, Juan José; Rémy, Vanessa (12 Ağustos 2015). "The intangible benefits of vaccination – what is the true economic value of vaccination?". Journal of Market Access & Health Policy. 3: 10.3402/jmahp.v3.26964. doi:10.3402/jmahp.v3.26964. ISSN 2001-6689. PMC 4802696 $2. PMID 27123182.
Frasca, Daniela; Diaz, Alain; Romero, Maria; Garcia, Denisse; Blomberg, Bonnie B. (6 Ekim 2020). "B Cell Immunosenescence". Annual Review of Cell and Developmental Biology. 36 (1): 551-574. doi:10.1146/annurev-cellbio-011620-034148. ISSN 1081-0706. PMC 8060858 $2. PMID 33021823. Erişim tarihi: 18 Nisan 2022.
Schlegel M, Osterwalder JJ, Galeazzi RL, Vernazza PL (August 1999). "Comparative efficacy of three mumps vaccines during disease outbreak in Eastern Switzerland: cohort study". BMJ. 319 (7206): 352. doi:10.1136/bmj.319.7206.352. PMC 32261 $2. PMID 10435956.
Préziosi MP, Halloran ME (September 2003). "Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity". Clinical Infectious Diseases. 37 (6): 772-779. doi:10.1086/377270. PMID 12955637.
Miller, E.; Beverley, P. C. L.; Salisbury, D. M. (1 Temmuz 2002). "Vaccine programmes and policies". British Medical Bulletin. 62 (1): 201-211. doi:10.1093/bmb/62.1.201. ISSN 0007-1420. PMID 12176861.
Orenstein WA, Papania MJ, Wharton ME (May 2004). "Measles elimination in the United States". The Journal of Infectious Diseases. 189 Suppl 1 (Suppl 1): S1-3. doi:10.1086/377693. PMID 15106120.
Grassly, Nicholas C. (5 Ağustos 2013). "The final stages of the global eradication of poliomyelitis". Philosophical Transactions of the Royal Society B: Biological Sciences. 368 (1623): 20120140. doi:10.1098/rstb.2012.0140. ISSN 0962-8436. PMC 3720038 $2. PMID 23798688.
Ittefaq, Muhammad; Abwao, Mauryne; Rafique, Shanawer (3 Ağustos 2021). "Polio vaccine misinformation on social media: turning point in the fight against polio eradication in Pakistan". Human Vaccines & Immunotherapeutics. 17 (8): 2575-2577. doi:10.1080/21645515.2021.1894897. ISSN 2164-554X. PMC 8475597 $2. PMID 33705246.
Dudley, Matthew Z; Halsey, Neal A; Omer, Saad B; Orenstein, Walter A; O'Leary, Sean T; Limaye, Rupali J; Salmon, Daniel A (May 2020). "The state of vaccine safety science: systematic reviews of the evidence". The Lancet Infectious Diseases. 20 (5): e80-e89. doi:10.1016/s1473-3099(20)30130-4. ISSN 1473-3099. PMID 32278359. 22 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Maglione MA, Das L, Raaen L, Smith A, Chari R, Newberry S, Shanman R, Perry T, Goetz MB, Gidengil C (August 2014). "Safety of vaccines used for routine immunization of U.S. children: a systematic review". Pediatrics. 134 (2): 325-337. doi:10.1542/peds.2014-1079. PMID 25086160. 30 Ocak 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Looker, Clare; Heath, Kelly (2011). "No-fault compensation following adverse events attributed to vaccination: a review of international programmes". Bulletin of the World Health Organization. Word Health Organisation. 89 (5): 371-378. doi:10.2471/BLT.10.081901. PMC 3089384 $2. PMID 21556305. 11 Ağustos 2013 tarihinde kaynağından arşivlendi.
Batah, Aly; Ahmad, Tarek (15 Haziran 2020). "The development of ghost vaccines trials". Expert Review of Vaccines (İngilizce). 19 (6): 549-562. doi:10.1080/14760584.2020.1777862. ISSN 1476-0584. PMID 32500816. 25 Nisan 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Williamson, E. D.; Eley, S. M.; Griffin, K. F.; Green, M.; Russell, P.; Leary, S. E.; Oyston, P. C.; Easterbrook, T.; Reddin, K. M. (December 1995). "A new improved sub-unit vaccine for plague: the basis of protection". FEMS Immunology and Medical Microbiology. 12 (3–4): 223-230. doi:10.1111/j.1574-695X.1995.tb00196.x. ISSN 0928-8244. PMID 8745007.
Pollard AJ, Bijker EM (22 Aralık 2020). "A guide to vaccinology: from basic principles to new developments". Nature Reviews Immunology. 21 (2): 83-100. doi:10.1038/s41577-020-00479-7. ISSN 1474-1741. PMC 7754704 $2. PMID 33353987.
Pol L, Stork M, Ley P (11 Kasım 2015). "Outer membrane vesicles as platform vaccine technology". Biotechnology Journal. 10 (11): 1689-1706. doi:10.1002/biot.201400395. ISSN 1860-7314. PMC 4768646 $2. PMID 26912077.
Kim W, Liau LM (January 2010). "Dendritic cell vaccines for brain tumors". Neurosurgery Clinics of North America. 21 (1): 139-157. doi:10.1016/j.nec.2009.09.005. PMC 2810429 $2. PMID 19944973.
Anguille S, Smits EL, Lion E, van Tendeloo VF, Berneman ZN (June 2014). "Clinical use of dendritic cells for cancer therapy". The Lancet. Oncology. 15 (7): e257-267. doi:10.1016/S1470-2045(13)70585-0. PMID 24872109.
Meri S, Jördens M, Jarva H (December 2008). "Microbial complement inhibitors as vaccines". Vaccine. 26 Suppl 8: I113-117. doi:10.1016/j.vaccine.2008.11.058. PMID 19388175.
Gizurarson, Sveinbj??rn (1998). "Clinically Relevant Vaccine-Vaccine Interactions: A Guide for Practitioners". BioDrugs. 9 (6): 443-453. doi:10.2165/00063030-199809060-00002.
Kanesa-thasan N, Sun W, Kim-Ahn G, Van Albert S, Putnak JR, King A, Raengsakulsrach B, Christ-Schmidt H, Gilson K, Zahradnik JM, Vaughn DW, Innis BL, Saluzzo JF, Hoke CH (April 2001). "Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers". Vaccine. 19 (23–24): 3179-3188. CiteSeerX 10.1.1.559.8311 $2. doi:10.1016/S0264-410X(01)00020-2. PMID 11312014.
Engler, Renata J. M.; Greenwood, John T.; Pittman, Phillip R.; Grabenstein, John D. (1 Ağustos 2006). "Immunization to Protect the US Armed Forces: Heritage, Current Practice, and Prospects". Epidemiologic Reviews. 28 (1): 3-26. doi:10.1093/epirev/mxj003. ISSN 0193-936X. PMID 16763072.
Bigham M, Copes R (2005). "Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease". Drug Safety. 28 (2): 89-101. doi:10.2165/00002018-200528020-00001. PMID 15691220.
Offit PA (September 2007). "Thimerosal and vaccines – a cautionary tale". The New England Journal of Medicine. 357 (13): 1278-1279. doi:10.1056/NEJMp078187. PMID 17898096.
Bok, Karin; Sitar, Sandra; Graham, Barney S.; Mascola, John R. (August 2021). "Accelerated COVID-19 vaccine development: milestones, lessons, and prospects". Immunity. 54 (8): 1636-1651. doi:10.1016/j.immuni.2021.07.017. PMC 8328682 $2. PMID 34348117.
Wijnans, Leonoor; Voordouw, Bettie (11 Aralık 2015). "A review of the changes to the licensing of influenza vaccines in Europe". Influenza and Other Respiratory Viruses. 10 (1): 2-8. doi:10.1111/irv.12351. ISSN 1750-2640. PMC 4687503 $2. PMID 26439108.
Dooling, Kathleen; Marin, Mona; Wallace, Megan; McClung, Nancy; Chamberland, Mary; Lee, Grace M.; Talbot, H. Keipp; Romero, José R.; Bell, Beth P.; Oliver, Sara E. (December 2020). "The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine – United States, December 2020". MMWR. Morbidity and Mortality Weekly Report. 69 (5152): 1657-1660. doi:10.15585/mmwr.mm695152e2. PMC 9191902 $2. PMID 33382671.
Steffen, Christoph A.; Henaff, Louise; Durupt, Antoine; El Omeiri, Nathalie; Ndiaye, Sidy; Batmunkh, Nyambat; Liyanage, Jayantha B. L.; Hasan, Quamrul; Mosina, Liudmila; Jones, Ian; O'Brien, Katherine; Hombach, Joachim (8 Nisan 2021). "Evidence-informed vaccination decision-making in countries: Progress, challenges and opportunities". Vaccine. Elsevier. 39 (15): 2146-2152. doi:10.1016/j.vaccine.2021.02.055. PMID 33712350.
Hunziker, Patrick (24 Temmuz 2021). "Personalized-dose Covid-19 vaccination in a wave of virus Variants of Concern: Trading individual efficacy for societal benefit". Precision Nanomedicine (İngilizce). 4 (3): 805-820. doi:10.33218/001c.26101. ISSN 2639-9431. 9 Ekim 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Olesen OF, Lonnroth A, Mulligan B (January 2009). "Human vaccine research in the European Union". Vaccine. 27 (5): 640-645. doi:10.1016/j.vaccine.2008.11.064. PMC 7115654 $2. PMID 19059446.
Jit M, Newall AT, Beutels P (April 2013). "Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies". Human Vaccines & Immunotherapeutics. 9 (4): 834-840. doi:10.4161/hv.23637. PMC 3903903 $2. PMID 23357859.
Newall AT, Reyes JF, Wood JG, McIntyre P, Menzies R, Beutels P (February 2014). "Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses". Vaccine. 32 (7): 759-765. doi:10.1016/j.vaccine.2013.11.067. PMID 24295806.
Plotkin, Stanley; Robinson, James M.; Cunningham, Gerard; Iqbal, Robyn; Larsen, Shannon (24 Temmuz 2017). "The complexity and cost of vaccine manufacturing – An overview". Vaccine. 35 (33): 4064-4071. doi:10.1016/j.vaccine.2017.06.003. PMC 5518734 $2. PMID 28647170.
Muzumdar JM, Cline RR (2009). "Vaccine supply, demand, and policy: a primer". Journal of the American Pharmacists Association. 49 (4): e87-99. doi:10.1331/JAPhA.2009.09007. PMC 7185851 $2. PMID 19589753.
Bae K, Choi J, Jang Y, Ahn S, Hur B (April 2009). "Innovative vaccine production technologies: the evolution and value of vaccine production technologies". Archives of Pharmacal Research. 32 (4): 465-480. doi:10.1007/s12272-009-1400-1. PMID 19407962.
Pagliusi, Sonia; Jarrett, Stephen; Hayman, Benoit; Kreysa, Ulrike; Prasad, Sai D.; Reers, Martin; Hong Thai, Pham; Wu, Ke; Zhang, Youn Tao; Baek, Yeong Ok; Kumar, Anand (July 2020). "Emerging manufacturers engagements in the COVID −19 vaccine research, development and supply". Vaccine (İngilizce). 38 (34): 5418-5423. doi:10.1016/j.vaccine.2020.06.022. PMC 7287474 $2. PMID 32600908.
Morein B, Hu KF, Abusugra I (June 2004). "Current status and potential application of ISCOMs in veterinary medicine". Advanced Drug Delivery Reviews. 56 (10): 1367-1382. doi:10.1016/j.addr.2004.02.004. PMID 15191787.
Giudice EL, Campbell JD (April 2006). "Needle-free vaccine delivery". Advanced Drug Delivery Reviews. 58 (1): 68-89. doi:10.1016/j.addr.2005.12.003. PMID 16564111.
Patel JR, Heldens JG (March 2009). "Immunoprophylaxis against important virus disease of horses, farm animals and birds". Vaccine. 27 (12): 1797-1810. doi:10.1016/j.vaccine.2008.12.063. PMC 7130586 $2. PMID 19402200.
Berkelman RL (August 2003). "Human illness associated with use of veterinary vaccines". Clinical Infectious Diseases. 37 (3): 407-414. doi:10.1086/375595. PMID 12884166.
van Oirschot JT, Rziha HJ, Moonen PJ, Pol JM, van Zaane D (June 1986). "Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay". The Journal of General Virology. 67 (Pt 6) (6): 1179-1182. doi:10.1099/0022-1317-67-6-1179. PMID 3011974.
van Oirschot JT (August 1999). "Diva vaccines that reduce virus transmission". Journal of Biotechnology. 73 (2–3): 195-205. doi:10.1016/S0168-1656(99)00121-2. PMID 10486928.
van Oirschot JT, Gielkens AL, Moormann RJ, Berns AJ (June 1990). "Marker vaccines, virus protein-specific antibody assays and the control of Aujeszky's disease". Veterinary Microbiology. 23 (1–4): 85-101. doi:10.1016/0378-1135(90)90139-M. PMID 2169682.
Kaashoek MJ, Moerman A, Madić J, Rijsewijk FA, Quak J, Gielkens AL, van Oirschot JT (April 1994). "A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine". Vaccine. 12 (5): 439-444. doi:10.1016/0264-410X(94)90122-8. PMID 8023552.
Hulst MM, Westra DF, Wensvoort G, Moormann RJ (September 1993). "Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera". Journal of Virology. 67 (9): 5435-5442. doi:10.1128/JVI.67.9.5435-5442.1993. PMC 237945 $2. PMID 8350404.
Capua I, Terregino C, Cattoli G, Mutinelli F, Rodriguez JF (February 2003). "Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza". Avian Pathology. 32 (1): 47-55. doi:10.1080/0307945021000070714. PMID 12745380.
Maas A, Meens J, Baltes N, Hennig-Pauka I, Gerlach GF (November 2006). "Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection". Vaccine. 24 (49–50): 7226-7237. doi:10.1016/j.vaccine.2006.06.047. PMID 17027123.
Leyman B, Boyen F, Van Parys A, Verbrugghe E, Haesebrouck F, Pasmans F (May 2011). "Salmonella Typhimurium LPS mutations for use in vaccines allowing differentiation of infected and vaccinated pigs". Vaccine. 29 (20): 3679-3685. doi:10.1016/j.vaccine.2011.03.004. hdl:1854/LU-1201519. PMID 21419163. 28 Ekim 2017 tarihinde kaynağından arşivlendi.
Baxby, Derrick (1984). "A Death from Inoculated Smallpox in the English Royal Family". Med Hist. 28 (3): 303-307. doi:10.1017/s0025727300035961. PMC 1139449 $2. PMID 6390027.
Stern AM, Markel H (2005). "The history of vaccines and immunization: familiar patterns, unew challenges". Health Affairs. 24 (3): 611-621. doi:10.1377/hlthaff.24.3.611. PMID 15886151.
Dunn PM (January 1996). "Dr Edward Jenner (1749-1823) of Berkeley, and vaccination against smallpox" (PDF). Archives of Disease in Childhood: Fetal and Neonatal Edition. 74 (1): F77-78. doi:10.1136/fn.74.1.F77. PMC 2528332 $2. PMID 8653442. 8 Temmuz 2011 tarihinde kaynağından (PDF) arşivlendi.
Van Sant JE (2008). "The Vaccinators: Smallpox, Medical Knowledge, and the 'Opening' of Japan". J Hist Med Allied Sci. 63 (2): 276-279. doi:10.1093/jhmas/jrn014.
Didgeon JA (May 1963). "Development of Smallpox Vaccine in England in the Eighteenth and Nineteenth Centuries". British Medical Journal. 1 (5342): 1367-1372. doi:10.1136/bmj.1.5342.1367. PMC 2124036 $2. PMID 20789814.
Baarda BI, Sikora AE (2015). "Proteomics of Neisseria gonorrhoeae: the treasure hunt for countermeasures against an old disease". Frontiers in Microbiology. 6: 1190. doi:10.3389/fmicb.2015.01190. PMC 4620152 $2. PMID 26579097; Access provided by the University of Pittsburgh.
Alarcon JB, Waine GW, McManus DP (1999). "DNA Vaccines: Technology and Application as Anti-parasite and Anti-microbial Agents". Advances in Parasitology Volume 42. Advances in Parasitology. 42. ss. 343-410. doi:10.1016/S0065-308X(08)60152-9. ISBN 9780120317424. PMID 10050276.
Robinson HL, Pertmer TM (2000). DNA vaccines for viral infections: basic studies and applications. Advances in Virus Research. 55. ss. 1-74. doi:10.1016/S0065-3527(00)55001-5. ISBN 9780120398553. PMID 11050940.
Chen Y, Wang S, Lu S (February 2014). "DNA Immunization for HIV Vaccine Development". Vaccines. 2 (1): 138-159. doi:10.3390/vaccines2010138. PMC 4494200 $2. PMID 26344472.
Spohn G, Bachmann MF (February 2008). "Exploiting viral properties for the rational design of modern vaccines". Expert Review of Vaccines. 7 (1): 43-54. doi:10.1586/14760584.7.1.43. PMID 18251693.
Samuelsson O, Herlitz H (March 2008). "Vaccination against high blood pressure: a new strategy". Lancet. 371 (9615): 788-789. doi:10.1016/S0140-6736(08)60355-4. PMID 18328909.
Poland GA, Jacobson RM, Ovsyannikova IG (May 2009). "Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics". Vaccine. 27 (25–26): 3240-3244. doi:10.1016/j.vaccine.2009.01.069. PMC 2693340 $2. PMID 19200833.
Sala F, Manuela Rigano M, Barbante A, Basso B, Walmsley AM, Castiglione S (January 2003). "Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives". Vaccine. 21 (7–8): 803-808. doi:10.1016/s0264-410x(02)00603-5. PMID 12531364.
Kumar GB, Ganapathi TR, Revathi CJ, Srinivas L, Bapat VA (October 2005). "Expression of hepatitis B surface antigen in transgenic banana plants". Planta. 222 (3): 484-493. doi:10.1007/s00425-005-1556-y. PMID 15918027.
The Lancet Child & Adolescent Health (2019). "Vaccine hesitancy: a generation at risk". The Lancet. 3 (5): 281. doi:10.1016/S2352-4642(19)30092-6. PMID 30981382.
Smith, MJ (November 2015). "Promoting Vaccine Confidence". Infectious Disease Clinics of North America (Review). 29 (4): 759-69. doi:10.1016/j.idc.2015.07.004. PMID 26337737.
Larson, HJ; Jarrett, C; Eckersberger, E; Smith, DM; Paterson, P (April 2014). "Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012". Vaccine. 32 (19): 2150-59. doi:10.1016/j.vaccine.2014.01.081. PMID 24598724.
Cataldi, Jessica; O'Leary, Sean (2021). "Parental vaccine hesitancy: scope, causes, and potential responses". Current Opinion in Infectious Diseases. 34 (5): 519-526. doi:10.1097/QCO.0000000000000774. PMID 34524202. 27 Ekim 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
"Communicating science-based messages on vaccines". Bulletin of the World Health Organization. 95 (10): 670-71. October 2017. doi:10.2471/BLT.17.021017. PMC 5689193 $2. PMID 29147039.
Phadke VK, Bednarczyk RA, Salmon DA, Omer SB (March 2016). "Association Between Vaccine Refusal and Vaccine Preventable Diseases in the United States: A Review of Measles and Pertussis". JAMA. 315 (11): 1149-58. doi:10.1001/jama.2016.1353. PMC 5007135 $2. PMID 26978210.
Wolfe R, Sharp L (2002). "Anti-vaccinationists past and present". BMJ. 325 (7361): 430-2. doi:10.1136/bmj.325.7361.430. PMC 1123944 $2. PMID 12193361. 25 Ağustos 2006 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Poland GA, Jacobson RM (January 2011). "The age-old struggle against the antivaccinationists". The New England Journal of Medicine. 364 (2): 97-99. doi:10.1056/NEJMp1010594. PMID 21226573. 5 Mart 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Poland GA, Jacobson RM (March 2001). "Understanding those who do not understand: a brief review of the anti-vaccine movement". Vaccine. 19 (17–19): 2440-45. doi:10.1016/S0264-410X(00)00469-2. PMID 11257375.

emory.edu

globalhealthprimer.emory.edu

"Polysaccharide Protein Conjugate Vaccines". www.globalhealthprimer.emory.edu. 23 Haziran 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Haziran 2019.

escholarship.org

Maglione MA, Das L, Raaen L, Smith A, Chari R, Newberry S, Shanman R, Perry T, Goetz MB, Gidengil C (August 2014). "Safety of vaccines used for routine immunization of U.S. children: a systematic review". Pediatrics. 134 (2): 325-337. doi:10.1542/peds.2014-1079. PMID 25086160. 30 Ocak 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.

europa.eu

ema.europa.eu

"Zostavax EPAR". European Medicines Agency (EMA). 29 Temmuz 2021. 5 Ağustos 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 1 Eylül 2021.

fda.gov

"Thimerosal in vaccines". Center for Biologics Evaluation and Research, U.S. Food and Drug Administration. 6 Eylül 2007. 6 Ocak 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 1 Ekim 2007.
Nutrition, Center for Food Safety and Applied (25 Şubat 2022). "Mercury Levels in Commercial Fish and Shellfish (1990-2012)". FDA (İngilizce). 23 Mart 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
"Vaccine product approval process". U.S. Food and Drug Administration (FDA). 30 Ocak 2020. 27 Eylül 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 17 Ağustos 2020.

ft.com

Miller, Joe; Kuchler, Hannah (28 Nisan 2020). "Drugmakers race to scale up vaccine capacity". www.ft.com (İngilizce). 10 Aralık 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 26 Temmuz 2020.

ghostarchive.org

Miller, Joe; Kuchler, Hannah (28 Nisan 2020). "Drugmakers race to scale up vaccine capacity". www.ft.com (İngilizce). 10 Aralık 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 26 Temmuz 2020.

handle.net

hdl.handle.net

Gomes, M. Gabriela M.; White, Lisa J.; Medley, Graham F. (21 Haziran 2004). "Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives". Journal of Theoretical Biology. 228 (4): 539-549. Bibcode:2004JThBi.228..539G. doi:10.1016/j.jtbi.2004.02.015. hdl:10400.7/53. ISSN 0022-5193. PMID 15178201. 19 Nisan 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Nisan 2022.
Leyman B, Boyen F, Van Parys A, Verbrugghe E, Haesebrouck F, Pasmans F (May 2011). "Salmonella Typhimurium LPS mutations for use in vaccines allowing differentiation of infected and vaccinated pigs". Vaccine. 29 (20): 3679-3685. doi:10.1016/j.vaccine.2011.03.004. hdl:1854/LU-1201519. PMID 21419163. 28 Ekim 2017 tarihinde kaynağından arşivlendi.

harvard.edu

adsabs.harvard.edu

Ledford, Heidi (17 Ağustos 2020). "What the immune response to the coronavirus says about the prospects for a vaccine". Nature (İngilizce). 585 (7823): 20-21. Bibcode:2020Natur.585...20L. doi:10.1038/d41586-020-02400-7. PMID 32811981.
Gomes, M. Gabriela M.; White, Lisa J.; Medley, Graham F. (21 Haziran 2004). "Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives". Journal of Theoretical Biology. 228 (4): 539-549. Bibcode:2004JThBi.228..539G. doi:10.1016/j.jtbi.2004.02.015. hdl:10400.7/53. ISSN 0022-5193. PMID 15178201. 19 Nisan 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Nisan 2022.

healthychildren.org

"Vaccine Safety: The Facts". HealthyChildren.org. 16 Nisan 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Nisan 2019.

hhs.gov

Wharton, Melinda E.; National Vaccine Advisory committee "U.S.A. national vaccine plan" 4 Mayıs 2016 tarihinde Wayback Machine sitesinde arşivlendi.
Goodman, Jesse L. (4 Mayıs 2005). "Statement by Jesse L. Goodman, M.D., M.P.H. Director Center for Biologics, Evaluation and Research Food and Drug Administration U.S. Department of Health and Human Services on US Influenza Vaccine Supply and Preparations for the Upcoming Influenza Season before Subcommittee on Oversight and Investigations Committee on Energy and Commerce United States House of Representatives". 21 Eylül 2008 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Haziran 2008.

historyofvaccines.org

"Different Types of Vaccines | History of Vaccines". www.historyofvaccines.org. 26 Ocak 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Haziran 2019.
"Different Types of Vaccines | History of Vaccines". www.historyofvaccines.org. 26 Ocak 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Mayıs 2019.

horizonpress.com

Lowe (2008). "Plasmid DNA as Prophylactic and Therapeutic vaccines for Cancer and Infectious Diseases". Plasmids: Current Research and Future Trends. Caister Academic Press. ISBN 978-1-904455-35-6.

iowa.gov

legis.iowa.gov

"Expanded Practice Standards" (PDF). Iowa Administrative Code. 2019. 19 Ocak 2023 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 18 Nisan 2023.

japantimes.co.jp

Staff (28 Mart 2013). "Safer vaccine created without virus". The Japan Times. Agence France-Presse – Jiji Press. 30 Mart 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 28 Mart 2013.

jhu.edu

hub.jhu.edu

Jan 11, Hub staff report / Published; 2017 (11 Ocak 2017). "The science is clear: Vaccines are safe, effective, and do not cause autism". The Hub. 28 Eylül 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Nisan 2019.

lexology.com

Naftalis, Kramer Levin; Royzman, Frankel LLP-Irena; Pineda, ré (30 Kasım 2020). "Third-Generation Vaccines Take Center Stage in Battle Against COVID-19 | Lexology". www.lexology.com (İngilizce). 30 Ocak 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Ocak 2021.

lww.com

journals.lww.com

Cataldi, Jessica; O'Leary, Sean (2021). "Parental vaccine hesitancy: scope, causes, and potential responses". Current Opinion in Infectious Diseases. 34 (5): 519-526. doi:10.1097/QCO.0000000000000774. PMID 34524202. 27 Ekim 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.

mercksource.com

Polyvalent vaccine at Dorlands Medical Dictionary 7 Mart 2012 tarihinde Wayback Machine sitesinde arşivlendi.

nationalpost.com

March 5, Reuters Updated; 2019 (5 Mart 2019). "Another study, this one of 657k kids, finds MMR vaccine doesn't cause autism | Montreal Gazette". National Post. Erişim tarihi: 13 Mart 2019.

nature.com

"19 July 2017 Vaccines promoted as key to stamping out drug-resistant microbes "Immunization can stop resistant infections before they get started, say scientists from industry and academia."". 22 Temmuz 2017 tarihinde kaynağından arşivlendi.

news-medical.net

"Needle-free nanopatch vaccine delivery system". News Medical. 3 Ağustos 2011. 11 Mayıs 2012 tarihinde kaynağından arşivlendi.

newsweek.com

PM, Aristos Georgiou (15 Ocak 2019). "The anti-vax movement has been listed by WHO as one of its top 10 health threats for 2019" (İngilizce). 22 Kasım 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Ocak 2019.

nhs.uk

"HPV vaccine in the clear". NHS choices. 2 Ekim 2009. 10 Ocak 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Ocak 2014.

nih.gov

ncbi.nlm.nih.gov

Amanna, Ian J.; Slifka, Mark K. (2018). "Successful Vaccines". Current Topics in Microbiology and Immunology. Plant Disease. 428. Springer International Publishing. ss. 1-30. doi:10.1007/82_2018_102. eISSN 2196-9965. ISBN 978-3-030-58003-2. ISSN 0070-217X. PMC 6777997 $2. PMID 34129355. The effect of vaccines on public health is truly remarkable. One study examining the impact of childhood vaccination on the 2001 US birth cohort found that vaccines prevented 33,000 deaths and 14 million cases of disease (Zhou et al. 2005). Among 73 nations supported by the GAVI alliance, mathematical models project that vaccines will prevent 23.3 million deaths from 2011–2020 compared to what would have occurred if there were no vaccines available (Lee et al. 2013). Vaccines have been developed against a wide assortment of human pathogens.
Melief CJ, van Hall T, Arens R, Ossendorp F, van der Burg SH (September 2015). "Therapeutic cancer vaccines". The Journal of Clinical Investigation. 125 (9): 3401-3412. doi:10.1172/JCI80009. PMC 4588240 $2. PMID 26214521.
Bol KF, Aarntzen EH, Pots JM, Olde Nordkamp MA, van de Rakt MW, Scharenborg NM, de Boer AJ, van Oorschot TG, Croockewit SA, Blokx WA, Oyen WJ, Boerman OC, Mus RD, van Rossum MM, van der Graaf CA, Punt CJ, Adema GJ, Figdor CG, de Vries IJ, Schreibelt G (March 2016). "Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity". Cancer Immunology, Immunotherapy. 65 (3): 327-339. doi:10.1007/s00262-016-1796-7. PMC 4779136 $2. PMID 26861670.
Frazer IH (May 2014). "Development and implementation of papillomavirus prophylactic vaccines". Journal of Immunology. 192 (9): 4007-4011. doi:10.4049/jimmunol.1490012. PMID 24748633.
Ledford, Heidi (17 Ağustos 2020). "What the immune response to the coronavirus says about the prospects for a vaccine". Nature (İngilizce). 585 (7823): 20-21. Bibcode:2020Natur.585...20L. doi:10.1038/d41586-020-02400-7. PMID 32811981.
Lombard M, Pastoret PP, Moulin AM (April 2007). "A brief history of vaccines and vaccination". Revue Scientifique et Technique. 26 (1): 29-48. doi:10.20506/rst.26.1.1724. PMID 17633292.
Behbehani AM (December 1983). "The smallpox story: life and death of an old disease". Microbiological Reviews. 47 (4): 455-509. doi:10.1128/MMBR.47.4.455-509.1983. PMC 281588 $2. PMID 6319980.
Baxby D (January 1999). "Edward Jenner's Inquiry; a bicentenary analysis". Vaccine. 17 (4): 301-307. doi:10.1016/s0264-410x(98)00207-2. PMID 9987167.
Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, Sirotkin B (1985). "Field evaluation of vaccine efficacy". Bulletin of the World Health Organization. 63 (6): 1055-1068. PMC 2536484 $2. PMID 3879673.
Ellenberg SS, Chen RT (1997). "The complicated task of monitoring vaccine safety". Public Health Reports. 112 (1): 10-20; discussion 21. PMC 1381831 $2. PMID 9018282.
Clem, Angela S (2011). "Fundamentals of Vaccine Immunology". Journal of Global Infectious Diseases. 3 (1): 73-78. doi:10.4103/0974-777X.77299. ISSN 0974-777X. PMC 3068582 $2. PMID 21572612.
Grammatikos AP, Mantadakis E, Falagas ME (June 2009). "Meta-analyses on pediatric infections and vaccines". Infectious Disease Clinics of North America. 23 (2): 431-457. doi:10.1016/j.idc.2009.01.008. PMID 19393917.
Wiedermann, Ursula; Garner-Spitzer, Erika; Wagner, Angelika (2016). "Primary vaccine failure to routine vaccines: Why and what to do?". Human Vaccines & Immunotherapeutics. 12 (1): 239-243. doi:10.1080/21645515.2015.1093263. ISSN 2164-554X. PMC 4962729 $2. PMID 26836329.
Justiz Vaillant, AA; Ramphul, K (January 2022). Antibody Deficiency Disorder. Treasure Island, FL: StatPearls Publishing. PMID 29939682. Erişim tarihi: 18 Nisan 2022.
Reda, Shereen M.; Cant, Andrew J. (May 2015). "The importance of vaccination and immunoglobulin treatment for patients with primary immunodeficiency diseases (PIDs) - World PI Week April 22-29, 2015: FORUM". European Journal of Immunology (İngilizce). 45 (5): 1285-1286. doi:10.1002/eji.201570054. PMID 25952627. Erişim tarihi: 18 Nisan 2022.
Jo, Eun-Kyeong (December 2019). "Interplay between host and pathogen: immune defense and beyond". Experimental & Molecular Medicine (İngilizce). 51 (12): 1-3. doi:10.1038/s12276-019-0281-8. ISSN 2092-6413. PMC 6906370 $2. PMID 31827066.
Janeway, Charles A Jr.; Travers, Paul; Walport, Mark; Shlomchik, Mark J. (2001). "The Humoral Immune Response". Immunobiology: The Immune System in Health and Disease. 5th Edition (İngilizce). 2 Ocak 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2022.
Grubbs, Hailey; Kahwaji, Chadi I. (January 2022). Physiology, Active Immunity. Treasure Island, FL: StatPearls Publishing. PMID 29939682. 12 Kasım 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2022.
Gomes, M. Gabriela M.; White, Lisa J.; Medley, Graham F. (21 Haziran 2004). "Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives". Journal of Theoretical Biology. 228 (4): 539-549. Bibcode:2004JThBi.228..539G. doi:10.1016/j.jtbi.2004.02.015. hdl:10400.7/53. ISSN 0022-5193. PMID 15178201. 19 Nisan 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Nisan 2022.
Bonanni, Paolo; Picazo, Juan José; Rémy, Vanessa (12 Ağustos 2015). "The intangible benefits of vaccination – what is the true economic value of vaccination?". Journal of Market Access & Health Policy. 3: 10.3402/jmahp.v3.26964. doi:10.3402/jmahp.v3.26964. ISSN 2001-6689. PMC 4802696 $2. PMID 27123182.
Frasca, Daniela; Diaz, Alain; Romero, Maria; Garcia, Denisse; Blomberg, Bonnie B. (6 Ekim 2020). "B Cell Immunosenescence". Annual Review of Cell and Developmental Biology. 36 (1): 551-574. doi:10.1146/annurev-cellbio-011620-034148. ISSN 1081-0706. PMC 8060858 $2. PMID 33021823. Erişim tarihi: 18 Nisan 2022.
Schlegel M, Osterwalder JJ, Galeazzi RL, Vernazza PL (August 1999). "Comparative efficacy of three mumps vaccines during disease outbreak in Eastern Switzerland: cohort study". BMJ. 319 (7206): 352. doi:10.1136/bmj.319.7206.352. PMC 32261 $2. PMID 10435956.
Préziosi MP, Halloran ME (September 2003). "Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity". Clinical Infectious Diseases. 37 (6): 772-779. doi:10.1086/377270. PMID 12955637.
Miller, E.; Beverley, P. C. L.; Salisbury, D. M. (1 Temmuz 2002). "Vaccine programmes and policies". British Medical Bulletin. 62 (1): 201-211. doi:10.1093/bmb/62.1.201. ISSN 0007-1420. PMID 12176861.
Orenstein WA, Papania MJ, Wharton ME (May 2004). "Measles elimination in the United States". The Journal of Infectious Diseases. 189 Suppl 1 (Suppl 1): S1-3. doi:10.1086/377693. PMID 15106120.
"Measles – United States, January 1 – April 25, 2008". MMWR. Morbidity and Mortality Weekly Report. 57 (18): 494-498. May 2008. PMID 18463608. 11 Ekim 2017 tarihinde kaynağından arşivlendi.
Grassly, Nicholas C. (5 Ağustos 2013). "The final stages of the global eradication of poliomyelitis". Philosophical Transactions of the Royal Society B: Biological Sciences. 368 (1623): 20120140. doi:10.1098/rstb.2012.0140. ISSN 0962-8436. PMC 3720038 $2. PMID 23798688.
Ittefaq, Muhammad; Abwao, Mauryne; Rafique, Shanawer (3 Ağustos 2021). "Polio vaccine misinformation on social media: turning point in the fight against polio eradication in Pakistan". Human Vaccines & Immunotherapeutics. 17 (8): 2575-2577. doi:10.1080/21645515.2021.1894897. ISSN 2164-554X. PMC 8475597 $2. PMID 33705246.
Dudley, Matthew Z; Halsey, Neal A; Omer, Saad B; Orenstein, Walter A; O'Leary, Sean T; Limaye, Rupali J; Salmon, Daniel A (May 2020). "The state of vaccine safety science: systematic reviews of the evidence". The Lancet Infectious Diseases. 20 (5): e80-e89. doi:10.1016/s1473-3099(20)30130-4. ISSN 1473-3099. PMID 32278359. 22 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Maglione MA, Das L, Raaen L, Smith A, Chari R, Newberry S, Shanman R, Perry T, Goetz MB, Gidengil C (August 2014). "Safety of vaccines used for routine immunization of U.S. children: a systematic review". Pediatrics. 134 (2): 325-337. doi:10.1542/peds.2014-1079. PMID 25086160. 30 Ocak 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Looker, Clare; Heath, Kelly (2011). "No-fault compensation following adverse events attributed to vaccination: a review of international programmes". Bulletin of the World Health Organization. Word Health Organisation. 89 (5): 371-378. doi:10.2471/BLT.10.081901. PMC 3089384 $2. PMID 21556305. 11 Ağustos 2013 tarihinde kaynağından arşivlendi.
Batah, Aly; Ahmad, Tarek (15 Haziran 2020). "The development of ghost vaccines trials". Expert Review of Vaccines (İngilizce). 19 (6): 549-562. doi:10.1080/14760584.2020.1777862. ISSN 1476-0584. PMID 32500816. 25 Nisan 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Williamson, E. D.; Eley, S. M.; Griffin, K. F.; Green, M.; Russell, P.; Leary, S. E.; Oyston, P. C.; Easterbrook, T.; Reddin, K. M. (December 1995). "A new improved sub-unit vaccine for plague: the basis of protection". FEMS Immunology and Medical Microbiology. 12 (3–4): 223-230. doi:10.1111/j.1574-695X.1995.tb00196.x. ISSN 0928-8244. PMID 8745007.
Pollard AJ, Bijker EM (22 Aralık 2020). "A guide to vaccinology: from basic principles to new developments". Nature Reviews Immunology. 21 (2): 83-100. doi:10.1038/s41577-020-00479-7. ISSN 1474-1741. PMC 7754704 $2. PMID 33353987.
Pol L, Stork M, Ley P (11 Kasım 2015). "Outer membrane vesicles as platform vaccine technology". Biotechnology Journal. 10 (11): 1689-1706. doi:10.1002/biot.201400395. ISSN 1860-7314. PMC 4768646 $2. PMID 26912077.
Kim W, Liau LM (January 2010). "Dendritic cell vaccines for brain tumors". Neurosurgery Clinics of North America. 21 (1): 139-157. doi:10.1016/j.nec.2009.09.005. PMC 2810429 $2. PMID 19944973.
Anguille S, Smits EL, Lion E, van Tendeloo VF, Berneman ZN (June 2014). "Clinical use of dendritic cells for cancer therapy". The Lancet. Oncology. 15 (7): e257-267. doi:10.1016/S1470-2045(13)70585-0. PMID 24872109.
Meri S, Jördens M, Jarva H (December 2008). "Microbial complement inhibitors as vaccines". Vaccine. 26 Suppl 8: I113-117. doi:10.1016/j.vaccine.2008.11.058. PMID 19388175.
Kanesa-thasan N, Sun W, Kim-Ahn G, Van Albert S, Putnak JR, King A, Raengsakulsrach B, Christ-Schmidt H, Gilson K, Zahradnik JM, Vaughn DW, Innis BL, Saluzzo JF, Hoke CH (April 2001). "Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers". Vaccine. 19 (23–24): 3179-3188. CiteSeerX 10.1.1.559.8311 $2. doi:10.1016/S0264-410X(01)00020-2. PMID 11312014.
Engler, Renata J. M.; Greenwood, John T.; Pittman, Phillip R.; Grabenstein, John D. (1 Ağustos 2006). "Immunization to Protect the US Armed Forces: Heritage, Current Practice, and Prospects". Epidemiologic Reviews. 28 (1): 3-26. doi:10.1093/epirev/mxj003. ISSN 0193-936X. PMID 16763072.
Sox, Harold C.; Liverman, Catharyn T.; Fulco, Carolyn E.; War, Institute of Medicine (US) Committee on Health Effects Associated with Exposures During the Gulf (2000). Vaccines. National Academies Press (US). 16 Kasım 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Bigham M, Copes R (2005). "Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease". Drug Safety. 28 (2): 89-101. doi:10.2165/00002018-200528020-00001. PMID 15691220.
Offit PA (September 2007). "Thimerosal and vaccines – a cautionary tale". The New England Journal of Medicine. 357 (13): 1278-1279. doi:10.1056/NEJMp078187. PMID 17898096.
Bok, Karin; Sitar, Sandra; Graham, Barney S.; Mascola, John R. (August 2021). "Accelerated COVID-19 vaccine development: milestones, lessons, and prospects". Immunity. 54 (8): 1636-1651. doi:10.1016/j.immuni.2021.07.017. PMC 8328682 $2. PMID 34348117.
Wijnans, Leonoor; Voordouw, Bettie (11 Aralık 2015). "A review of the changes to the licensing of influenza vaccines in Europe". Influenza and Other Respiratory Viruses. 10 (1): 2-8. doi:10.1111/irv.12351. ISSN 1750-2640. PMC 4687503 $2. PMID 26439108.
Dooling, Kathleen; Marin, Mona; Wallace, Megan; McClung, Nancy; Chamberland, Mary; Lee, Grace M.; Talbot, H. Keipp; Romero, José R.; Bell, Beth P.; Oliver, Sara E. (December 2020). "The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine – United States, December 2020". MMWR. Morbidity and Mortality Weekly Report. 69 (5152): 1657-1660. doi:10.15585/mmwr.mm695152e2. PMC 9191902 $2. PMID 33382671.
Steffen, Christoph A.; Henaff, Louise; Durupt, Antoine; El Omeiri, Nathalie; Ndiaye, Sidy; Batmunkh, Nyambat; Liyanage, Jayantha B. L.; Hasan, Quamrul; Mosina, Liudmila; Jones, Ian; O'Brien, Katherine; Hombach, Joachim (8 Nisan 2021). "Evidence-informed vaccination decision-making in countries: Progress, challenges and opportunities". Vaccine. Elsevier. 39 (15): 2146-2152. doi:10.1016/j.vaccine.2021.02.055. PMID 33712350.
Dooling, Kathleen (13 Ağustos 2021). "The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine – United States, December 2020" (PDF). CDC the Advisory Committee on Immunization Practices. 69 (5152): 1657-1660. PMC 9191902 $2. PMID 33382671. 19 Ağustos 2021 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 18 Nisan 2023.
Olesen OF, Lonnroth A, Mulligan B (January 2009). "Human vaccine research in the European Union". Vaccine. 27 (5): 640-645. doi:10.1016/j.vaccine.2008.11.064. PMC 7115654 $2. PMID 19059446.
Jit M, Newall AT, Beutels P (April 2013). "Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies". Human Vaccines & Immunotherapeutics. 9 (4): 834-840. doi:10.4161/hv.23637. PMC 3903903 $2. PMID 23357859.
Newall AT, Reyes JF, Wood JG, McIntyre P, Menzies R, Beutels P (February 2014). "Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses". Vaccine. 32 (7): 759-765. doi:10.1016/j.vaccine.2013.11.067. PMID 24295806.
Plotkin, Stanley; Robinson, James M.; Cunningham, Gerard; Iqbal, Robyn; Larsen, Shannon (24 Temmuz 2017). "The complexity and cost of vaccine manufacturing – An overview". Vaccine. 35 (33): 4064-4071. doi:10.1016/j.vaccine.2017.06.003. PMC 5518734 $2. PMID 28647170.
Muzumdar JM, Cline RR (2009). "Vaccine supply, demand, and policy: a primer". Journal of the American Pharmacists Association. 49 (4): e87-99. doi:10.1331/JAPhA.2009.09007. PMC 7185851 $2. PMID 19589753.
Bae K, Choi J, Jang Y, Ahn S, Hur B (April 2009). "Innovative vaccine production technologies: the evolution and value of vaccine production technologies". Archives of Pharmacal Research. 32 (4): 465-480. doi:10.1007/s12272-009-1400-1. PMID 19407962.
Pagliusi, Sonia; Jarrett, Stephen; Hayman, Benoit; Kreysa, Ulrike; Prasad, Sai D.; Reers, Martin; Hong Thai, Pham; Wu, Ke; Zhang, Youn Tao; Baek, Yeong Ok; Kumar, Anand (July 2020). "Emerging manufacturers engagements in the COVID −19 vaccine research, development and supply". Vaccine (İngilizce). 38 (34): 5418-5423. doi:10.1016/j.vaccine.2020.06.022. PMC 7287474 $2. PMID 32600908.
Morein B, Hu KF, Abusugra I (June 2004). "Current status and potential application of ISCOMs in veterinary medicine". Advanced Drug Delivery Reviews. 56 (10): 1367-1382. doi:10.1016/j.addr.2004.02.004. PMID 15191787.
Giudice EL, Campbell JD (April 2006). "Needle-free vaccine delivery". Advanced Drug Delivery Reviews. 58 (1): 68-89. doi:10.1016/j.addr.2005.12.003. PMID 16564111.
Patel JR, Heldens JG (March 2009). "Immunoprophylaxis against important virus disease of horses, farm animals and birds". Vaccine. 27 (12): 1797-1810. doi:10.1016/j.vaccine.2008.12.063. PMC 7130586 $2. PMID 19402200.
Berkelman RL (August 2003). "Human illness associated with use of veterinary vaccines". Clinical Infectious Diseases. 37 (3): 407-414. doi:10.1086/375595. PMID 12884166.
van Oirschot JT, Rziha HJ, Moonen PJ, Pol JM, van Zaane D (June 1986). "Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay". The Journal of General Virology. 67 (Pt 6) (6): 1179-1182. doi:10.1099/0022-1317-67-6-1179. PMID 3011974.
van Oirschot JT (August 1999). "Diva vaccines that reduce virus transmission". Journal of Biotechnology. 73 (2–3): 195-205. doi:10.1016/S0168-1656(99)00121-2. PMID 10486928.
van Oirschot JT, Gielkens AL, Moormann RJ, Berns AJ (June 1990). "Marker vaccines, virus protein-specific antibody assays and the control of Aujeszky's disease". Veterinary Microbiology. 23 (1–4): 85-101. doi:10.1016/0378-1135(90)90139-M. PMID 2169682.
Kaashoek MJ, Moerman A, Madić J, Rijsewijk FA, Quak J, Gielkens AL, van Oirschot JT (April 1994). "A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine". Vaccine. 12 (5): 439-444. doi:10.1016/0264-410X(94)90122-8. PMID 8023552.
Hulst MM, Westra DF, Wensvoort G, Moormann RJ (September 1993). "Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera". Journal of Virology. 67 (9): 5435-5442. doi:10.1128/JVI.67.9.5435-5442.1993. PMC 237945 $2. PMID 8350404.
Capua I, Terregino C, Cattoli G, Mutinelli F, Rodriguez JF (February 2003). "Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza". Avian Pathology. 32 (1): 47-55. doi:10.1080/0307945021000070714. PMID 12745380.
Maas A, Meens J, Baltes N, Hennig-Pauka I, Gerlach GF (November 2006). "Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection". Vaccine. 24 (49–50): 7226-7237. doi:10.1016/j.vaccine.2006.06.047. PMID 17027123.
Leyman B, Boyen F, Van Parys A, Verbrugghe E, Haesebrouck F, Pasmans F (May 2011). "Salmonella Typhimurium LPS mutations for use in vaccines allowing differentiation of infected and vaccinated pigs". Vaccine. 29 (20): 3679-3685. doi:10.1016/j.vaccine.2011.03.004. hdl:1854/LU-1201519. PMID 21419163. 28 Ekim 2017 tarihinde kaynağından arşivlendi.
Baxby, Derrick (1984). "A Death from Inoculated Smallpox in the English Royal Family". Med Hist. 28 (3): 303-307. doi:10.1017/s0025727300035961. PMC 1139449 $2. PMID 6390027.
Stern AM, Markel H (2005). "The history of vaccines and immunization: familiar patterns, unew challenges". Health Affairs. 24 (3): 611-621. doi:10.1377/hlthaff.24.3.611. PMID 15886151.
Dunn PM (January 1996). "Dr Edward Jenner (1749-1823) of Berkeley, and vaccination against smallpox" (PDF). Archives of Disease in Childhood: Fetal and Neonatal Edition. 74 (1): F77-78. doi:10.1136/fn.74.1.F77. PMC 2528332 $2. PMID 8653442. 8 Temmuz 2011 tarihinde kaynağından (PDF) arşivlendi.
Didgeon JA (May 1963). "Development of Smallpox Vaccine in England in the Eighteenth and Nineteenth Centuries". British Medical Journal. 1 (5342): 1367-1372. doi:10.1136/bmj.1.5342.1367. PMC 2124036 $2. PMID 20789814.
Baarda BI, Sikora AE (2015). "Proteomics of Neisseria gonorrhoeae: the treasure hunt for countermeasures against an old disease". Frontiers in Microbiology. 6: 1190. doi:10.3389/fmicb.2015.01190. PMC 4620152 $2. PMID 26579097; Access provided by the University of Pittsburgh.
Alarcon JB, Waine GW, McManus DP (1999). "DNA Vaccines: Technology and Application as Anti-parasite and Anti-microbial Agents". Advances in Parasitology Volume 42. Advances in Parasitology. 42. ss. 343-410. doi:10.1016/S0065-308X(08)60152-9. ISBN 9780120317424. PMID 10050276.
Robinson HL, Pertmer TM (2000). DNA vaccines for viral infections: basic studies and applications. Advances in Virus Research. 55. ss. 1-74. doi:10.1016/S0065-3527(00)55001-5. ISBN 9780120398553. PMID 11050940.
Chen Y, Wang S, Lu S (February 2014). "DNA Immunization for HIV Vaccine Development". Vaccines. 2 (1): 138-159. doi:10.3390/vaccines2010138. PMC 4494200 $2. PMID 26344472.
Spohn G, Bachmann MF (February 2008). "Exploiting viral properties for the rational design of modern vaccines". Expert Review of Vaccines. 7 (1): 43-54. doi:10.1586/14760584.7.1.43. PMID 18251693.
Samuelsson O, Herlitz H (March 2008). "Vaccination against high blood pressure: a new strategy". Lancet. 371 (9615): 788-789. doi:10.1016/S0140-6736(08)60355-4. PMID 18328909.
Poland GA, Jacobson RM, Ovsyannikova IG (May 2009). "Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics". Vaccine. 27 (25–26): 3240-3244. doi:10.1016/j.vaccine.2009.01.069. PMC 2693340 $2. PMID 19200833.
Sala F, Manuela Rigano M, Barbante A, Basso B, Walmsley AM, Castiglione S (January 2003). "Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives". Vaccine. 21 (7–8): 803-808. doi:10.1016/s0264-410x(02)00603-5. PMID 12531364.
Kumar GB, Ganapathi TR, Revathi CJ, Srinivas L, Bapat VA (October 2005). "Expression of hepatitis B surface antigen in transgenic banana plants". Planta. 222 (3): 484-493. doi:10.1007/s00425-005-1556-y. PMID 15918027.
The Lancet Child & Adolescent Health (2019). "Vaccine hesitancy: a generation at risk". The Lancet. 3 (5): 281. doi:10.1016/S2352-4642(19)30092-6. PMID 30981382.
Smith, MJ (November 2015). "Promoting Vaccine Confidence". Infectious Disease Clinics of North America (Review). 29 (4): 759-69. doi:10.1016/j.idc.2015.07.004. PMID 26337737.
Larson, HJ; Jarrett, C; Eckersberger, E; Smith, DM; Paterson, P (April 2014). "Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012". Vaccine. 32 (19): 2150-59. doi:10.1016/j.vaccine.2014.01.081. PMID 24598724.
Cataldi, Jessica; O'Leary, Sean (2021). "Parental vaccine hesitancy: scope, causes, and potential responses". Current Opinion in Infectious Diseases. 34 (5): 519-526. doi:10.1097/QCO.0000000000000774. PMID 34524202. 27 Ekim 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
"Communicating science-based messages on vaccines". Bulletin of the World Health Organization. 95 (10): 670-71. October 2017. doi:10.2471/BLT.17.021017. PMC 5689193 $2. PMID 29147039.
Phadke VK, Bednarczyk RA, Salmon DA, Omer SB (March 2016). "Association Between Vaccine Refusal and Vaccine Preventable Diseases in the United States: A Review of Measles and Pertussis". JAMA. 315 (11): 1149-58. doi:10.1001/jama.2016.1353. PMC 5007135 $2. PMID 26978210.
Wolfe R, Sharp L (2002). "Anti-vaccinationists past and present". BMJ. 325 (7361): 430-2. doi:10.1136/bmj.325.7361.430. PMC 1123944 $2. PMID 12193361. 25 Ağustos 2006 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Poland GA, Jacobson RM (January 2011). "The age-old struggle against the antivaccinationists". The New England Journal of Medicine. 364 (2): 97-99. doi:10.1056/NEJMp1010594. PMID 21226573. 5 Mart 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Poland GA, Jacobson RM (March 2001). "Understanding those who do not understand: a brief review of the anti-vaccine movement". Vaccine. 19 (17–19): 2440-45. doi:10.1016/S0264-410X(00)00469-2. PMID 11257375.

pubmed.ncbi.nlm.nih.gov

Gomes, M. Gabriela M.; White, Lisa J.; Medley, Graham F. (21 Haziran 2004). "Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives". Journal of Theoretical Biology. 228 (4): 539-549. Bibcode:2004JThBi.228..539G. doi:10.1016/j.jtbi.2004.02.015. hdl:10400.7/53. ISSN 0022-5193. PMID 15178201. 19 Nisan 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Nisan 2022.

niaid.nih.gov

"Vaccine Types". National Institute of Allergy and Infectious Diseases. 3 Nisan 2012. 5 Eylül 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Ocak 2015.

npl.co.uk

"Measurements of Non-gaseous air pollutants > Metals". npl.co.uk. National Physics Laboratory. 29 Eylül 2007 tarihinde kaynağından arşivlendi. Erişim tarihi: 28 Haziran 2020.

npr.org

Neighmond, Patti (7 Şubat 2010). "Adapting Vaccines For Our Aging Immune Systems". Morning Edition. NPR. 16 Aralık 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Ocak 2014.

nytimes.com

Zimmer, Carl (20 Kasım 2020). "2 Companies Say Their Vaccines Are 95% Effective. What Does That Mean? You might assume that 95 out of every 100 people vaccinated will be protected from Covid-19. But that's not how the math works". The New York Times. 22 Kasım 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 Kasım 2020.
Hoffman, Jan (5 Mart 2019). "One More Time, With Big Data: Measles Vaccine Doesn't Cause Autism". The New York Times. ISSN 0362-4331. 12 Mart 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 13 Mart 2019.

ourworldindata.org

Roser, Max; Vanderslott, Samantha (10 Mayıs 2013). "Vaccination". Our World in Data. 1 Eylül 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.

pediatriconcall.com

"Questions And Answers On Monovalent Oral Polio Vaccine Type 1 (mOPV1)'Issued Jointly By WHO and UNICEF'". Pediatric Oncall. 3. What advantages does mOPV1 have over trivalent oral polio vaccine (tOPV)?. 2 (8). 8 Ocak 2005. 29 Şubat 2012 tarihinde kaynağından arşivlendi.

precisionnanomedicine.com

Hunziker, Patrick (24 Temmuz 2021). "Personalized-dose Covid-19 vaccination in a wave of virus Variants of Concern: Trading individual efficacy for societal benefit". Precision Nanomedicine (İngilizce). 4 (3): 805-820. doi:10.33218/001c.26101. ISSN 2639-9431. 9 Ekim 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.

psu.edu

citeseerx.ist.psu.edu

Kanesa-thasan N, Sun W, Kim-Ahn G, Van Albert S, Putnak JR, King A, Raengsakulsrach B, Christ-Schmidt H, Gilson K, Zahradnik JM, Vaughn DW, Innis BL, Saluzzo JF, Hoke CH (April 2001). "Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers". Vaccine. 19 (23–24): 3179-3188. CiteSeerX 10.1.1.559.8311 $2. doi:10.1016/S0264-410X(01)00020-2. PMID 11312014.

publishing.service.gov.uk

assets.publishing.service.gov.uk

"Vaccine Taskforce Aims" (PDF). assets.publishing.service.gov.uk. 6 Nisan 2020. 26 Temmuz 2020 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 26 Temmuz 2020.

sciencedirect.com

Mak, Tak W.; Saunders, Mary E.; Jett, Bradley D. (2014). "Chapter 1 - Introduction to the Immune Response". Primer to The immune response (İngilizce) (2. bas.). Burlington, MA: Academic Cell. ss. 3-20. ISBN 978-0-12-385245-8. Erişim tarihi: 18 Nisan 2022.

semanticscholar.org

Poland GA, Jacobson RM (January 2011). "The age-old struggle against the antivaccinationists". The New England Journal of Medicine. 364 (2): 97-99. doi:10.1056/NEJMp1010594. PMID 21226573. 5 Mart 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.

smh.com.au

"Australian scientists develop 'needle-free' vaccination". The Sydney Morning Herald. 18 Ağustos 2013. 25 Eylül 2015 tarihinde kaynağından arşivlendi.

smithsonianmag.com

Banks, Marcus A. (16 Temmuz 2020). "What Are mRNA Vaccines, and Could They Work Against COVID-19?". Smithsonian Magazine. 21 Aralık 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 Aralık 2020.

statnews.com

Garde, Damian; Feuerstein, Adam (1 Kasım 2020). "How nanotechnology helps mRNA Covid-19 vaccines work". STAT. 1 Aralık 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 Aralık 2020.
Branswell, Helen (19 Aralık 2020). "FDA grants authorization to Moderna's Covid-19 vaccine". STAT. 21 Aralık 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 Aralık 2020.

tandfonline.com

Batah, Aly; Ahmad, Tarek (15 Haziran 2020). "The development of ghost vaccines trials". Expert Review of Vaccines (İngilizce). 19 (6): 549-562. doi:10.1080/14760584.2020.1777862. ISSN 1476-0584. PMID 32500816. 25 Nisan 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.

technologyreview.com

Regalado, Antonio. "The U.S. government has begun testing its first Zika vaccine in humans". 21 Ağustos 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 6 Ağustos 2016.

theconversation.com

Ceccarelli, Leah. "Defending science: How the art of rhetoric can help". The Conversation (İngilizce). 5 Kasım 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 26 Kasım 2018.

theguardian.com

Ferguson, Donna (28 Mart 2021). "How Mary Wortley Montagu's bold experiment led to smallpox vaccine – 75 years before Jenner". the Guardian. 11 Temmuz 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Temmuz 2022.
Burgen, Stephen (27 Temmuz 2021). "Exhibition tells story of Spanish children used as vaccine 'fridges' in 1803". The Guardian (İngilizce). ISSN 0261-3077. 30 Ağustos 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 17 Nisan 2023.

thehindu.com

"Australian scientists develop 'needle-free' vaccination". The Hindu. Chennai, India. 28 Eylül 2011. 1 Ocak 2014 tarihinde kaynağından arşivlendi.

tribune.com.pk

"Disinformation disturbs anti-polio drives". The Express Tribune (İngilizce). 24 Ocak 2022. 10 Mayıs 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Nisan 2022.

ugent.be

biblio.ugent.be

Leyman B, Boyen F, Van Parys A, Verbrugghe E, Haesebrouck F, Pasmans F (May 2011). "Salmonella Typhimurium LPS mutations for use in vaccines allowing differentiation of infected and vaccinated pigs". Vaccine. 29 (20): 3679-3685. doi:10.1016/j.vaccine.2011.03.004. hdl:1854/LU-1201519. PMID 21419163. 28 Ekim 2017 tarihinde kaynağından arşivlendi.

vaccine-safety-training.org

"Components of a vaccine". 13 Haziran 2017 tarihinde kaynağından arşivlendi.

vaccines.gov

"Types of Vaccines". 29 Temmuz 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Ekim 2017.
"Vaccine Types". Vaccines.org. Office of Infectious Disease of the United States Department of Health and Human Services. 23 Mayıs 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 13 Mart 2021.
U.S. Department of Health and Human Services. "Vaccines.gov". Vaccines.gov (İngilizce). 13 Mart 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Ağustos 2018.

vaccinesafety.edu

"Institute for Vaccine Safety – Thimerosal Table". 10 Aralık 2005 tarihinde kaynağından arşivlendi.

vox.com

"Why do some people oppose vaccination?". Vox. 21 Eylül 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 26 Kasım 2018.

washingtonpost.com

Sullivan, Patricia (13 Nisan 2005). "Maurice R. Hilleman dies; created vaccines". Wash. Post. 20 Ekim 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Ocak 2014.
"Three ways to make a vaccine" (infographic). 23 Aralık 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Ağustos 2015 , in Stein, Rob (24 Kasım 2009). "Vaccine system remains antiquated". The Washington Post. 19 Ekim 2017 tarihinde kaynağından arşivlendi.

web.archive.org

"Expanded Practice Standards" (PDF). Iowa Administrative Code. 2019. 19 Ocak 2023 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 18 Nisan 2023.
"Immunization: The Basics". Centers for Disease Control and Prevention. 22 Kasım 2022. 12 Temmuz 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 Temmuz 2023.
Zimmer, Carl (20 Kasım 2020). "2 Companies Say Their Vaccines Are 95% Effective. What Does That Mean? You might assume that 95 out of every 100 people vaccinated will be protected from Covid-19. But that's not how the math works". The New York Times. 22 Kasım 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 Kasım 2020.
United States Centers for Disease Control and Prevention (2011). A CDC framework for preventing infectious diseases. 29 Ağustos 2017 tarihinde Wayback Machine sitesinde arşivlendi. Accessed 11 September 2012. "Vaccines are our most effective and cost-saving tools for disease prevention, preventing untold suffering and saving tens of thousands of lives and billions of dollars in healthcare costs each year."
"Global Vaccine Action Plan". www.who.int (İngilizce). 24 Ocak 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Nisan 2023.
Ferguson, Donna (28 Mart 2021). "How Mary Wortley Montagu's bold experiment led to smallpox vaccine – 75 years before Jenner". the Guardian. 11 Temmuz 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Temmuz 2022.
"Measles Vaccination CDC". 5 Şubat 2018. 19 Kasım 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Jan 11, Hub staff report / Published; 2017 (11 Ocak 2017). "The science is clear: Vaccines are safe, effective, and do not cause autism". The Hub. 28 Eylül 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Nisan 2019.
"Vaccine Safety: The Facts". HealthyChildren.org. 16 Nisan 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Nisan 2019.
Janeway, Charles A Jr.; Travers, Paul; Walport, Mark; Shlomchik, Mark J. (2001). "The Humoral Immune Response". Immunobiology: The Immune System in Health and Disease. 5th Edition (İngilizce). 2 Ocak 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2022.
Grubbs, Hailey; Kahwaji, Chadi I. (January 2022). Physiology, Active Immunity. Treasure Island, FL: StatPearls Publishing. PMID 29939682. 12 Kasım 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2022.
Gomes, M. Gabriela M.; White, Lisa J.; Medley, Graham F. (21 Haziran 2004). "Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives". Journal of Theoretical Biology. 228 (4): 539-549. Bibcode:2004JThBi.228..539G. doi:10.1016/j.jtbi.2004.02.015. hdl:10400.7/53. ISSN 0022-5193. PMID 15178201. 19 Nisan 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Nisan 2022.
Stanciu, Stefan G. (24 Ağustos 2016). Micro and Nanotechnologies for Biotechnology (İngilizce). BoD – Books on Demand. ISBN 978-953-51-2530-3. 14 Ocak 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Nisan 2022.
Neighmond, Patti (7 Şubat 2010). "Adapting Vaccines For Our Aging Immune Systems". Morning Edition. NPR. 16 Aralık 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Ocak 2014.
"Measles – United States, January 1 – April 25, 2008". MMWR. Morbidity and Mortality Weekly Report. 57 (18): 494-498. May 2008. PMID 18463608. 11 Ekim 2017 tarihinde kaynağından arşivlendi.
"WHO | Smallpox". WHO. World Health Organization. 22 Eylül 2007 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Nisan 2019.
"WHO South-East Asia Region certified polio-free". WHO. 27 Mart 2014. 27 Mart 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Kasım 2014.
"Statement following the Twenty-Eighth IHR Emergency Committee for Polio". World Health Organization (İngilizce). 21 Mayıs 2021. 19 Nisan 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Nisan 2022.
"Disinformation disturbs anti-polio drives". The Express Tribune (İngilizce). 24 Ocak 2022. 10 Mayıs 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Nisan 2022.
"19 July 2017 Vaccines promoted as key to stamping out drug-resistant microbes "Immunization can stop resistant infections before they get started, say scientists from industry and academia."". 22 Temmuz 2017 tarihinde kaynağından arşivlendi.
Sullivan, Patricia (13 Nisan 2005). "Maurice R. Hilleman dies; created vaccines". Wash. Post. 20 Ekim 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Ocak 2014.
Dudley, Matthew Z; Halsey, Neal A; Omer, Saad B; Orenstein, Walter A; O'Leary, Sean T; Limaye, Rupali J; Salmon, Daniel A (May 2020). "The state of vaccine safety science: systematic reviews of the evidence". The Lancet Infectious Diseases. 20 (5): e80-e89. doi:10.1016/s1473-3099(20)30130-4. ISSN 1473-3099. PMID 32278359. 22 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Maglione MA, Das L, Raaen L, Smith A, Chari R, Newberry S, Shanman R, Perry T, Goetz MB, Gidengil C (August 2014). "Safety of vaccines used for routine immunization of U.S. children: a systematic review". Pediatrics. 134 (2): 325-337. doi:10.1542/peds.2014-1079. PMID 25086160. 30 Ocak 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
"Possible Side-effects from Vaccines". Centers for Disease Control and Prevention. 12 Temmuz 2018. 17 Mart 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Şubat 2014.
"Seasonal Flu Shot – Seasonal Influenza (Flu)". CDC. 2 Ekim 2018. 1 Ekim 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 17 Eylül 2017.
Looker, Clare; Heath, Kelly (2011). "No-fault compensation following adverse events attributed to vaccination: a review of international programmes". Bulletin of the World Health Organization. Word Health Organisation. 89 (5): 371-378. doi:10.2471/BLT.10.081901. PMC 3089384 $2. PMID 21556305. 11 Ağustos 2013 tarihinde kaynağından arşivlendi.
"Vaccine Types". National Institute of Allergy and Infectious Diseases. 3 Nisan 2012. 5 Eylül 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Ocak 2015.
"Types of Vaccines". 29 Temmuz 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Ekim 2017.
Batah, Aly; Ahmad, Tarek (15 Haziran 2020). "The development of ghost vaccines trials". Expert Review of Vaccines (İngilizce). 19 (6): 549-562. doi:10.1080/14760584.2020.1777862. ISSN 1476-0584. PMID 32500816. 25 Nisan 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
"Different Types of Vaccines | History of Vaccines". www.historyofvaccines.org. 26 Ocak 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Haziran 2019.
"Different Types of Vaccines | History of Vaccines". www.historyofvaccines.org. 26 Ocak 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Mayıs 2019.
"Types of Vaccines". coastalcarolinaresearch.com. 3 Mayıs 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Mayıs 2019.
Philadelphia, The Children's Hospital of (18 Ağustos 2014). "A Look at Each Vaccine: Hepatitis B Vaccine". www.chop.edu. 31 Mayıs 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Haziran 2019.
"HPV Vaccine | Human Papillomavirus | CDC". www.cdc.gov. 13 Mayıs 2019. 18 Haziran 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Haziran 2019.
"Polysaccharide Protein Conjugate Vaccines". www.globalhealthprimer.emory.edu. 23 Haziran 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Haziran 2019.
Scott (April 2004). "Classifying Vaccines" (PDF). BioProcesses International: 14-23. 12 Aralık 2013 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 9 Ocak 2014.
"Vaccine Types". Vaccines.org. Office of Infectious Disease of the United States Department of Health and Human Services. 23 Mayıs 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 13 Mart 2021.
"Understanding and Explaining Viral Vector COVID-19 Vaccines". Centers for Disease Control and Prevention. 2 Şubat 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 13 Mart 2021.
Garde, Damian; Feuerstein, Adam (1 Kasım 2020). "How nanotechnology helps mRNA Covid-19 vaccines work". STAT. 1 Aralık 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 Aralık 2020.
CDC (11 Şubat 2020). "COVID-19 and Your Health". Centers for Disease Control and Prevention. 3 Mart 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 Aralık 2020.
Banks, Marcus A. (16 Temmuz 2020). "What Are mRNA Vaccines, and Could They Work Against COVID-19?". Smithsonian Magazine. 21 Aralık 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 Aralık 2020.
Branswell, Helen (19 Aralık 2020). "FDA grants authorization to Moderna's Covid-19 vaccine". STAT. 21 Aralık 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 Aralık 2020.
McKenzie, David (26 Mayıs 2018). "Fear and failure: How Ebola sparked a global health revolution". CNN. 26 Ağustos 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 26 Mayıs 2018.
Dorland's Medical Dictionary'de "Monovalent"
Polyvalent vaccine at Dorlands Medical Dictionary 7 Mart 2012 tarihinde Wayback Machine sitesinde arşivlendi.
"Questions And Answers On Monovalent Oral Polio Vaccine Type 1 (mOPV1)'Issued Jointly By WHO and UNICEF'". Pediatric Oncall. 3. What advantages does mOPV1 have over trivalent oral polio vaccine (tOPV)?. 2 (8). 8 Ocak 2005. 29 Şubat 2012 tarihinde kaynağından arşivlendi.
Sox, Harold C.; Liverman, Catharyn T.; Fulco, Carolyn E.; War, Institute of Medicine (US) Committee on Health Effects Associated with Exposures During the Gulf (2000). Vaccines. National Academies Press (US). 16 Kasım 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
"Institute for Vaccine Safety – Thimerosal Table". 10 Aralık 2005 tarihinde kaynağından arşivlendi.
Wharton, Melinda E.; National Vaccine Advisory committee "U.S.A. national vaccine plan" 4 Mayıs 2016 tarihinde Wayback Machine sitesinde arşivlendi.
"Measurements of Non-gaseous air pollutants > Metals". npl.co.uk. National Physics Laboratory. 29 Eylül 2007 tarihinde kaynağından arşivlendi. Erişim tarihi: 28 Haziran 2020.
"Thimerosal in vaccines". Center for Biologics Evaluation and Research, U.S. Food and Drug Administration. 6 Eylül 2007. 6 Ocak 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 1 Ekim 2007.
Hoffman, Jan (5 Mart 2019). "One More Time, With Big Data: Measles Vaccine Doesn't Cause Autism". The New York Times. ISSN 0362-4331. 12 Mart 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 13 Mart 2019.
CDC (12 Temmuz 2018). "Ingredients of Vaccines – Fact Sheet". 17 Aralık 2009 tarihinde kaynağından arşivlendi. Erişim tarihi: 20 Aralık 2009.
Nutrition, Center for Food Safety and Applied (25 Şubat 2022). "Mercury Levels in Commercial Fish and Shellfish (1990-2012)". FDA (İngilizce). 23 Mart 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Centers for Disease Control and Prevention (12 Kasım 2020), U.S. Vaccine Names, 21 Ağustos 2021 tarihinde kaynağından arşivlendi, erişim tarihi: 21 Ağustos 2021.
Centers for Disease Control and Prevention (7 Ağustos 2018), Tetanus (Lockjaw) Vaccination, 16 Mayıs 2016 tarihinde kaynağından arşivlendi, erişim tarihi: 21 Mayıs 2016.
Centers for Disease Control and Prevention (2 Şubat 2018), Vaccine Acronyms and Abbreviations [Abbreviations used on U.S. immunization records], 2 Haziran 2017 tarihinde kaynağından arşivlendi, erişim tarihi: 22 Mayıs 2017.
"Principles and considerations for adding a vaccine to a national immunization programme" (PDF). World Health Organization. 1 Nisan 2014. 29 Eylül 2020 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 17 Ağustos 2020.
Offit, Paul A. (2020). "Making vaccines: Licensure, recommendations and requirements". Children's Hospital of Philadelphia. 8 Eylül 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 20 Ağustos 2020.
Toner E, Barnill A, Krubiner C, Bernstein J, Privor-Dumm L, Watson M, Martin E, Potter C, Hosangadi D, Connell N, Watson C, Schoch-Spana M, Veenema TG, Meyer D, Biddison EL, Regenberg A, Inglesby T, Cicero A (2020). Interim Framework for COVID-19 Vaccine Allocation and Distribution in the United States (PDF). Baltimore, MD: Johns Hopkins Center for Health Security. 22 Ağustos 2020 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 24 Ağustos 2020.
"Vaccine product approval process". U.S. Food and Drug Administration (FDA). 30 Ocak 2020. 27 Eylül 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 17 Ağustos 2020.
"home". Cdsco.gov.in. 15 Nisan 2021. 4 Ocak 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Ocak 2022.
"ACIP Vaccine Recommendations Home Page". CDC. 15 Kasım 2013. 31 Aralık 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Ocak 2014.
"Vaccine Status Table". Red Book Online. American Academy of Pediatrics. 26 Nisan 2011. 27 Aralık 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Ocak 2013.
"HPV Vaccine Safety". Centers for Disease Control and Prevention (CDC). 20 Aralık 2013. 10 Kasım 2009 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Ocak 2014.
"HPV vaccine in the clear". NHS choices. 2 Ekim 2009. 10 Ocak 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Ocak 2014.
"Zostavax EPAR". European Medicines Agency (EMA). 29 Temmuz 2021. 5 Ağustos 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 1 Eylül 2021.
Dooling, Kathleen (13 Ağustos 2021). "The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine – United States, December 2020" (PDF). CDC the Advisory Committee on Immunization Practices. 69 (5152): 1657-1660. PMC 9191902 $2. PMID 33382671. 19 Ağustos 2021 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 18 Nisan 2023.
Hunziker, Patrick (24 Temmuz 2021). "Personalized-dose Covid-19 vaccination in a wave of virus Variants of Concern: Trading individual efficacy for societal benefit". Precision Nanomedicine (İngilizce). 4 (3): 805-820. doi:10.33218/001c.26101. ISSN 2639-9431. 9 Ekim 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Goodman, Jesse L. (4 Mayıs 2005). "Statement by Jesse L. Goodman, M.D., M.P.H. Director Center for Biologics, Evaluation and Research Food and Drug Administration U.S. Department of Health and Human Services on US Influenza Vaccine Supply and Preparations for the Upcoming Influenza Season before Subcommittee on Oversight and Investigations Committee on Energy and Commerce United States House of Representatives". 21 Eylül 2008 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Haziran 2008.
Roser, Max; Vanderslott, Samantha (10 Mayıs 2013). "Vaccination". Our World in Data. 1 Eylül 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
"Increasing Access to Vaccines Through Technology Transfer and Local Production" (PDF). World Health Organization. 2011. 23 Kasım 2015 tarihinde kaynağından arşivlendi (PDF).
Christy Somos (7 Mayıs 2021). "Everything you need to know about the WTO's COVID-19 vaccine patent proposal". CTV News. 23 Mayıs 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 23 Mayıs 2021.
"Three ways to make a vaccine" (infographic). 23 Aralık 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Ağustos 2015 , in Stein, Rob (24 Kasım 2009). "Vaccine system remains antiquated". The Washington Post. 19 Ekim 2017 tarihinde kaynağından arşivlendi.
"Components of a vaccine". 13 Haziran 2017 tarihinde kaynağından arşivlendi.
"Vaccine Taskforce Aims" (PDF). assets.publishing.service.gov.uk. 6 Nisan 2020. 26 Temmuz 2020 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 26 Temmuz 2020.
WHO to trial Nanopatch needle-free delivery system| ABC News, 16 Sep 2014| "Needle-free polio vaccine a 'game-changer'". ABC News. 16 Eylül 2014. 2 Nisan 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Eylül 2015.
"Australian scientists develop 'needle-free' vaccination". The Sydney Morning Herald. 18 Ağustos 2013. 25 Eylül 2015 tarihinde kaynağından arşivlendi.
"Vaxxas raises $25m to take Brisbane's Nanopatch global". Business Review Weekly. 10 Şubat 2015. 16 Mart 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mart 2015.
"Australian scientists develop 'needle-free' vaccination". The Hindu. Chennai, India. 28 Eylül 2011. 1 Ocak 2014 tarihinde kaynağından arşivlendi.
"Needle-free nanopatch vaccine delivery system". News Medical. 3 Ağustos 2011. 11 Mayıs 2012 tarihinde kaynağından arşivlendi.
Leyman B, Boyen F, Van Parys A, Verbrugghe E, Haesebrouck F, Pasmans F (May 2011). "Salmonella Typhimurium LPS mutations for use in vaccines allowing differentiation of infected and vaccinated pigs". Vaccine. 29 (20): 3679-3685. doi:10.1016/j.vaccine.2011.03.004. hdl:1854/LU-1201519. PMID 21419163. 28 Ekim 2017 tarihinde kaynağından arşivlendi.
Dunn PM (January 1996). "Dr Edward Jenner (1749-1823) of Berkeley, and vaccination against smallpox" (PDF). Archives of Disease in Childhood: Fetal and Neonatal Edition. 74 (1): F77-78. doi:10.1136/fn.74.1.F77. PMC 2528332 $2. PMID 8653442. 8 Temmuz 2011 tarihinde kaynağından (PDF) arşivlendi.
Burgen, Stephen (27 Temmuz 2021). "Exhibition tells story of Spanish children used as vaccine 'fridges' in 1803". The Guardian (İngilizce). ISSN 0261-3077. 30 Ağustos 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 17 Nisan 2023.
Naftalis, Kramer Levin; Royzman, Frankel LLP-Irena; Pineda, ré (30 Kasım 2020). "Third-Generation Vaccines Take Center Stage in Battle Against COVID-19 | Lexology". www.lexology.com (İngilizce). 30 Ocak 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Ocak 2021.
Regalado, Antonio. "The U.S. government has begun testing its first Zika vaccine in humans". 21 Ağustos 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 6 Ağustos 2016.
"Katalin Karikó and Drew Weissman Awarded Horwitz Prize for Pioneering Research on COVID-19 Vaccines". Columbia University Irving Medical Center (İngilizce). 12 Ağustos 2021. 16 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Eylül 2021.
Staff (28 Mart 2013). "Safer vaccine created without virus". The Japan Times. Agence France-Presse – Jiji Press. 30 Mart 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 28 Mart 2013.
Cataldi, Jessica; O'Leary, Sean (2021). "Parental vaccine hesitancy: scope, causes, and potential responses". Current Opinion in Infectious Diseases. 34 (5): 519-526. doi:10.1097/QCO.0000000000000774. PMID 34524202. 27 Ekim 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
"Why do some people oppose vaccination?". Vox. 21 Eylül 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 26 Kasım 2018.
Ceccarelli, Leah. "Defending science: How the art of rhetoric can help". The Conversation (İngilizce). 5 Kasım 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 26 Kasım 2018.
U.S. Department of Health and Human Services. "Vaccines.gov". Vaccines.gov (İngilizce). 13 Mart 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Ağustos 2018.
"Frequently Asked Questions (FAQ)". Boston Children's Hospital. 17 Ekim 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Şubat 2014.
Wolfe R, Sharp L (2002). "Anti-vaccinationists past and present". BMJ. 325 (7361): 430-2. doi:10.1136/bmj.325.7361.430. PMC 1123944 $2. PMID 12193361. 25 Ağustos 2006 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Poland GA, Jacobson RM (January 2011). "The age-old struggle against the antivaccinationists". The New England Journal of Medicine. 364 (2): 97-99. doi:10.1056/NEJMp1010594. PMID 21226573. 5 Mart 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Wallace A (19 Ekim 2009). "An epidemic of fear: how panicked parents skipping shots endangers us all". Wired. 25 Aralık 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 Ekim 2009.
"Ten threats to global health in 2019". Who.int (İngilizce). 27 Haziran 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Aralık 2020.
PM, Aristos Georgiou (15 Ocak 2019). "The anti-vax movement has been listed by WHO as one of its top 10 health threats for 2019" (İngilizce). 22 Kasım 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Ocak 2019.

who.int

"Global Vaccine Action Plan". www.who.int (İngilizce). 24 Ocak 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Nisan 2023.
"WHO | Smallpox". WHO. World Health Organization. 22 Eylül 2007 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Nisan 2019.
"Statement following the Twenty-Eighth IHR Emergency Committee for Polio". World Health Organization (İngilizce). 21 Mayıs 2021. 19 Nisan 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Nisan 2022.
Looker, Clare; Heath, Kelly (2011). "No-fault compensation following adverse events attributed to vaccination: a review of international programmes". Bulletin of the World Health Organization. Word Health Organisation. 89 (5): 371-378. doi:10.2471/BLT.10.081901. PMC 3089384 $2. PMID 21556305. 11 Ağustos 2013 tarihinde kaynağından arşivlendi.
"Increasing Access to Vaccines Through Technology Transfer and Local Production" (PDF). World Health Organization. 2011. 23 Kasım 2015 tarihinde kaynağından arşivlendi (PDF).
"Ten threats to global health in 2019". Who.int (İngilizce). 27 Haziran 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Aralık 2020.

searo.who.int

"WHO South-East Asia Region certified polio-free". WHO. 27 Mart 2014. 27 Mart 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Kasım 2014.

apps.who.int

"Principles and considerations for adding a vaccine to a national immunization programme" (PDF). World Health Organization. 1 Nisan 2014. 29 Eylül 2020 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 17 Ağustos 2020.

wired.com

Wallace A (19 Ekim 2009). "An epidemic of fear: how panicked parents skipping shots endangers us all". Wired. 25 Aralık 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 Ekim 2009.

worldcat.org

Amanna, Ian J.; Slifka, Mark K. (2018). "Successful Vaccines". Current Topics in Microbiology and Immunology. Plant Disease. 428. Springer International Publishing. ss. 1-30. doi:10.1007/82_2018_102. eISSN 2196-9965. ISBN 978-3-030-58003-2. ISSN 0070-217X. PMC 6777997 $2. PMID 34129355. The effect of vaccines on public health is truly remarkable. One study examining the impact of childhood vaccination on the 2001 US birth cohort found that vaccines prevented 33,000 deaths and 14 million cases of disease (Zhou et al. 2005). Among 73 nations supported by the GAVI alliance, mathematical models project that vaccines will prevent 23.3 million deaths from 2011–2020 compared to what would have occurred if there were no vaccines available (Lee et al. 2013). Vaccines have been developed against a wide assortment of human pathogens.
Clem, Angela S (2011). "Fundamentals of Vaccine Immunology". Journal of Global Infectious Diseases. 3 (1): 73-78. doi:10.4103/0974-777X.77299. ISSN 0974-777X. PMC 3068582 $2. PMID 21572612.
Wiedermann, Ursula; Garner-Spitzer, Erika; Wagner, Angelika (2016). "Primary vaccine failure to routine vaccines: Why and what to do?". Human Vaccines & Immunotherapeutics. 12 (1): 239-243. doi:10.1080/21645515.2015.1093263. ISSN 2164-554X. PMC 4962729 $2. PMID 26836329.
Jo, Eun-Kyeong (December 2019). "Interplay between host and pathogen: immune defense and beyond". Experimental & Molecular Medicine (İngilizce). 51 (12): 1-3. doi:10.1038/s12276-019-0281-8. ISSN 2092-6413. PMC 6906370 $2. PMID 31827066.
Gomes, M. Gabriela M.; White, Lisa J.; Medley, Graham F. (21 Haziran 2004). "Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives". Journal of Theoretical Biology. 228 (4): 539-549. Bibcode:2004JThBi.228..539G. doi:10.1016/j.jtbi.2004.02.015. hdl:10400.7/53. ISSN 0022-5193. PMID 15178201. 19 Nisan 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Nisan 2022.
Bonanni, Paolo; Picazo, Juan José; Rémy, Vanessa (12 Ağustos 2015). "The intangible benefits of vaccination – what is the true economic value of vaccination?". Journal of Market Access & Health Policy. 3: 10.3402/jmahp.v3.26964. doi:10.3402/jmahp.v3.26964. ISSN 2001-6689. PMC 4802696 $2. PMID 27123182.
Frasca, Daniela; Diaz, Alain; Romero, Maria; Garcia, Denisse; Blomberg, Bonnie B. (6 Ekim 2020). "B Cell Immunosenescence". Annual Review of Cell and Developmental Biology. 36 (1): 551-574. doi:10.1146/annurev-cellbio-011620-034148. ISSN 1081-0706. PMC 8060858 $2. PMID 33021823. Erişim tarihi: 18 Nisan 2022.
Miller, E.; Beverley, P. C. L.; Salisbury, D. M. (1 Temmuz 2002). "Vaccine programmes and policies". British Medical Bulletin. 62 (1): 201-211. doi:10.1093/bmb/62.1.201. ISSN 0007-1420. PMID 12176861.
Grassly, Nicholas C. (5 Ağustos 2013). "The final stages of the global eradication of poliomyelitis". Philosophical Transactions of the Royal Society B: Biological Sciences. 368 (1623): 20120140. doi:10.1098/rstb.2012.0140. ISSN 0962-8436. PMC 3720038 $2. PMID 23798688.
Ittefaq, Muhammad; Abwao, Mauryne; Rafique, Shanawer (3 Ağustos 2021). "Polio vaccine misinformation on social media: turning point in the fight against polio eradication in Pakistan". Human Vaccines & Immunotherapeutics. 17 (8): 2575-2577. doi:10.1080/21645515.2021.1894897. ISSN 2164-554X. PMC 8475597 $2. PMID 33705246.
Dudley, Matthew Z; Halsey, Neal A; Omer, Saad B; Orenstein, Walter A; O'Leary, Sean T; Limaye, Rupali J; Salmon, Daniel A (May 2020). "The state of vaccine safety science: systematic reviews of the evidence". The Lancet Infectious Diseases. 20 (5): e80-e89. doi:10.1016/s1473-3099(20)30130-4. ISSN 1473-3099. PMID 32278359. 22 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Batah, Aly; Ahmad, Tarek (15 Haziran 2020). "The development of ghost vaccines trials". Expert Review of Vaccines (İngilizce). 19 (6): 549-562. doi:10.1080/14760584.2020.1777862. ISSN 1476-0584. PMID 32500816. 25 Nisan 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Williamson, E. D.; Eley, S. M.; Griffin, K. F.; Green, M.; Russell, P.; Leary, S. E.; Oyston, P. C.; Easterbrook, T.; Reddin, K. M. (December 1995). "A new improved sub-unit vaccine for plague: the basis of protection". FEMS Immunology and Medical Microbiology. 12 (3–4): 223-230. doi:10.1111/j.1574-695X.1995.tb00196.x. ISSN 0928-8244. PMID 8745007.
Pollard AJ, Bijker EM (22 Aralık 2020). "A guide to vaccinology: from basic principles to new developments". Nature Reviews Immunology. 21 (2): 83-100. doi:10.1038/s41577-020-00479-7. ISSN 1474-1741. PMC 7754704 $2. PMID 33353987.
Pol L, Stork M, Ley P (11 Kasım 2015). "Outer membrane vesicles as platform vaccine technology". Biotechnology Journal. 10 (11): 1689-1706. doi:10.1002/biot.201400395. ISSN 1860-7314. PMC 4768646 $2. PMID 26912077.
Engler, Renata J. M.; Greenwood, John T.; Pittman, Phillip R.; Grabenstein, John D. (1 Ağustos 2006). "Immunization to Protect the US Armed Forces: Heritage, Current Practice, and Prospects". Epidemiologic Reviews. 28 (1): 3-26. doi:10.1093/epirev/mxj003. ISSN 0193-936X. PMID 16763072.
Hoffman, Jan (5 Mart 2019). "One More Time, With Big Data: Measles Vaccine Doesn't Cause Autism". The New York Times. ISSN 0362-4331. 12 Mart 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 13 Mart 2019.
Wijnans, Leonoor; Voordouw, Bettie (11 Aralık 2015). "A review of the changes to the licensing of influenza vaccines in Europe". Influenza and Other Respiratory Viruses. 10 (1): 2-8. doi:10.1111/irv.12351. ISSN 1750-2640. PMC 4687503 $2. PMID 26439108.
Hunziker, Patrick (24 Temmuz 2021). "Personalized-dose Covid-19 vaccination in a wave of virus Variants of Concern: Trading individual efficacy for societal benefit". Precision Nanomedicine (İngilizce). 4 (3): 805-820. doi:10.33218/001c.26101. ISSN 2639-9431. 9 Ekim 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Nisan 2023.
Burgen, Stephen (27 Temmuz 2021). "Exhibition tells story of Spanish children used as vaccine 'fridges' in 1803". The Guardian (İngilizce). ISSN 0261-3077. 30 Ağustos 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 17 Nisan 2023.